<SEC-DOCUMENT>0001193125-24-174318.txt : 20240702
<SEC-HEADER>0001193125-24-174318.hdr.sgml : 20240702
<ACCEPTANCE-DATETIME>20240702160555
ACCESSION NUMBER:		0001193125-24-174318
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240626
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240702
DATE AS OF CHANGE:		20240702

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vera Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001831828
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				812744449
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40407
		FILM NUMBER:		241095137

	BUSINESS ADDRESS:	
		STREET 1:		8000 MARINA BOULEVARD, SUITE 120
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
		BUSINESS PHONE:		650-770-0077

	MAIL ADDRESS:	
		STREET 1:		8000 MARINA BOULEVARD, SUITE 120
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d799103d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:vera="http://veratx.com/20240626" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-307">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-06-26_to_2024-06-26">0001831828</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="vera-20240626.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-06-26_to_2024-06-26"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001831828</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-06-26</xbrli:startDate> <xbrli:endDate>2024-06-26</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-318">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-06-26_to_2024-06-26" format="ixt:datemonthdayyearen" id="ixv-319">June&#160;26, 2024</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-320">Vera Therapeutics, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-06-26_to_2024-06-26" format="ixt-sec:stateprovnameen" id="ixv-321">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-322">001-40407</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-323">81-2744449</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:33%"/>
<td style="vertical-align:bottom"/>
<td style="width:31%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-324">8000 Marina Boulevard</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-325">Suite 120</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-326">Brisbane</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-06-26_to_2024-06-26" format="ixt-sec:stateprovnameen" id="ixv-327">California</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-328">94005</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-329">(650)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-330">770-0077</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-06-26_to_2024-06-26" format="ixt-sec:boolballotbox" id="ixv-331">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-06-26_to_2024-06-26" format="ixt-sec:boolballotbox" id="ixv-332">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-06-26_to_2024-06-26" format="ixt-sec:boolballotbox" id="ixv-333">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-06-26_to_2024-06-26" format="ixt-sec:boolballotbox" id="ixv-334">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-335">Class&#160;A common stock, $0.001 par value per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-336">VERA</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-06-26_to_2024-06-26" format="ixt-sec:exchnameen" id="ixv-337">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-06-26_to_2024-06-26" format="ixt-sec:boolballotbox" id="ixv-338">&#9746;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;<ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2024-06-26_to_2024-06-26" format="ixt-sec:boolballotbox" id="ixv-339">&#9744;</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Appointment of David Johnson as Chief Operating Officer </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;1, 2024, Vera Therapeutics, Inc. (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Company</span></span>&#8221;) announced the appointment of David Johnson as the Company&#8217;s Chief Operating Officer, effective July&#160;1, 2024 (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Start Date</span></span>&#8221;). Mr.&#160;Johnson will serve as the Company&#8217;s principal operating officer in such role. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Johnson, age 55, previously served as Chief Commercial Officer of Global Blood Therapeutics (a biotechnology company acquired by Pfizer Inc.), a position he held from March 2018 to December 2022, where he led the global commercial functions and facilitated the launch of Oxbryta<sup style="font-size:75%; vertical-align:top">&#174;</sup> in 2019. Previously, Mr.&#160;Johnson was employed by Gilead Sciences, Inc., a biopharmaceutical company, from 2003 to 2018, where he held roles of increasing responsibility in the company&#8217;s commercial organization, including as vice president, sales and marketing, Liver Disease Business Unit, where he was instrumental in building and leading Gilead&#8217;s liver disease franchise, including launching four medicines for hepatitis. Prior to that, Mr.&#160;Johnson led the Antiviral Business Unit at Gilead, where he helped launch and oversee the HIV franchise. Before Gilead, he had an <span style="white-space:nowrap">11-year</span> tenure at GlaxoSmithKline, a biopharmaceutical company, where he held various positions in sales, product marketing, business development, global commercial strategy, and portfolio development. Mr.&#160;Johnson received his B.A. in Business Marketing from the University of Puget Sound and his M.B.A. from the Kenan-Flagler Business School at the University of North Carolina. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with Mr.&#160;Johnson&#8217;s appointment, the Company entered into an offer letter agreement with Mr.&#160;Johnson (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Offer Letter</span></span>&#8221;). Under the terms of the Offer Letter, Mr.&#160;Johnson will receive an annual base salary of $500,000 per year. He is eligible to receive an annual performance bonus of up to 40% of his base salary, <span style="white-space:nowrap">pro-rated</span> in calendar year 2024 for the partial year of service, based on the Company&#8217;s assessment of his performance and the Company&#8217;s attainment of written targeted goals as set by the Company in its sole discretion. Pursuant to the Offer Letter, Mr.&#160;Johnson also received an option to purchase 160,000 shares of the Company&#8217;s Class&#160;A common stock with an exercise price per share of $36.29 (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Option</span></span>&#8221;). The Option will be subject to the terms of the Company&#8217;s 2024 Inducement Plan and a stock option agreement by and between the Company and Mr.&#160;Johnson. The Option will vest subject to Mr.&#160;Johnson&#8217;s continued employment over a period of four years, with 25% of the Option shares vesting on the first anniversary of the Start Date, and the remaining shares subject to the Option vesting in 36 equal monthly installments thereafter, in each case subject to Mr.&#160;Johnson&#8217;s continued employment through the applicable vesting dates. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If (a)&#160;the Company terminates Mr.&#160;Johnson&#8217;s employment without Cause (as defined in the Offer Letter) or (b)&#160;Mr.&#160;Johnson resigns for Good Reason (as defined in the Offer Letter) (such terminations in &#8220;a&#8221; and &#8220;b&#8221; referred to as a&#160;&#8220;<span style="font-weight:bold"><span style="font-style:italic">Qualifying Termination</span></span>&#8221;), provided such termination or resignation constitutes a Separation from Service (as defined under Treasury Regulation <span style="white-space:nowrap">Section&#160;1.409A-1(h),</span> without regard to any alternative definition thereunder, a&#160;&#8220;<span style="font-weight:bold"><span style="font-style:italic">Separation from Service</span></span>&#8221;), then the Company will provide severance benefits including (i)&#160;nine months of Mr.&#160;Johnson&#8217;s base salary in effect as of the Qualifying Termination date, paid in installments on the Company&#8217;s ordinary payroll dates (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Severance</span></span>&#8221;) and (ii)&#160;the cost of Mr.&#160;Johnson&#8217;s and his dependents&#8217; health care coverage in effect at the time of the Separation from Service for a maximum of nine months, either under the Company&#8217;s regular health plan or by paying Mr.&#160;Johnson&#8217;s and his dependents&#8217; COBRA premiums (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">COBRA Severance</span></span>&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of a Qualifying Termination within three months prior to or within 12 months following the closing of a Change in Control (as defined in the Offer Letter), the Company will (a)&#160;accelerate the vesting of any of Mr.&#160;Johnson&#8217;s then-unvested equity in the Company such that 100% of such equity shall be deemed immediately vested and exercisable as of Mr.&#160;Johnson&#8217;s Separation from Service date; and (b)&#160;increase the amount of Severance and COBRA Severance to 12 months, and add to the cash component, as an additional severance benefit, an amount equal to Mr.&#160;Johnson&#8217;s target annual performance bonus for the year of Mr.&#160;Johnson&#8217;s Qualifying Termination, with such cash component to be paid in a single lump sum within 10 business days after the effective date of the Release (as defined in the Offer Letter). </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is no arrangement or understanding between Mr.&#160;Johnson and any other person pursuant to which he was selected as an officer of the Company, and there are no family relationships between Mr.&#160;Johnson and any of the Company&#8217;s directors or executive officers. There are no transactions to which the Company is a party and in which Mr.&#160;Johnson has a direct or indirect material interest that would be required to be disclosed under Item 404(a) of <span style="white-space:nowrap">Regulation&#160;S-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the terms of Mr.&#160;Johnson&#8217;s employment is not complete and is qualified in its entirety by reference to the Offer Letter, a copy of which is filed herewith as Exhibit 10.1 to this Current Report on Form <span style="white-space:nowrap">8-K.</span> </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br/>No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d799103dex101.htm">Offer Letter, by and between the Company and David Johnson, dated June&#160;26, 2024. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL Document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Vera Therapeutics, Inc. </p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3">Dated: July&#160;2, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Marshall Fordyce, M.D.</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Marshall Fordyce, M.D.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Executive Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d799103dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g799103g0702111704948.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June&nbsp;26, 2024 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">REVISED
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Employment Terms </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear David: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of Vera Therapeutics, Inc. (the
&#147;<B>Company</B>&#148;), I am pleased to offer you employment at the Company on the terms set forth in this offer letter agreement (this &#147;<B>Agreement</B>&#148;). As discussed, the terms of this Agreement govern with respect to your
employment, which shall commence no later than July&nbsp;1, 2024 (such actual date of your commencement of employment shall be referred to herein as the &#147;<B>Start Date</B>&#148;). </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Employment by the Company. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&#8195;<B>Position. </B>You will serve as the Company&#146;s Chief Operating Officer. During the term of your employment with the
Company, you will devote your best efforts and substantially all of your business time and attention to the business of the Company, except for approved vacation periods and reasonable periods of illness or other incapacities permitted by the
Company&#146;s general employment policies. It is anticipated that such business of the Company will include your providing services to entities that are subsidiaries of the Company or otherwise affiliated with the Company, without further or
additional compensation or benefits other than as set forth in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&#8195;<B>Duties and Location. </B>You will
perform such duties and responsibilities as are customary for your position or as may be directed by the Chief Executive Officer, to whom you report. Your primary office location will be the Company&#146;s office in Brisbane, California.
Notwithstanding the foregoing, the Company reserves the right to reasonably require you to perform your duties at places other than your primary office location from time to time, and to require reasonable business travel. The Company may modify
your job title and duties as it deems necessary and appropriate in light of the Company&#146;s needs and interests from time to time. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Base Salary and Employee Benefits. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&#8195;<B>Salary.</B> You will receive for services to be rendered hereunder a base salary paid at the rate of $500,000 per year,
less standard payroll deductions and tax withholdings. Your base salary will be paid on the Company&#146;s ordinary payroll cycle. As an exempt salaried employee, you will be required to work the Company&#146;s normal business hours, and such
additional time as appropriate for your work assignments and position, and you will not be entitled to overtime compensation. Your base salary rate may be changed by the Company in its sole discretion and shall be reviewed by the Company no less
than once per calendar year, starting in the calendar year 2025. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&#8195;<B>Benefits.</B> As a regular full-time employee, you
will be eligible to participate in the Company&#146;s standard employee benefits (pursuant to the terms and conditions of the benefit plans and applicable policies, as may be amended from time to time), all of which are described in summary plan
descriptions and policies that will be available or provided to you by the Company. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3.</B>&#8195;<B>Annual Bonus. </B>Commencing with calendar year 2024, you will be eligible to earn an
annual performance bonus of up to 40% of your base salary rate (the &#147;<B>Annual Bonus</B>&#148;), <FONT STYLE="white-space:nowrap">pro-rated</FONT> for the portion of 2024 that you were employed by the Company. The Annual Bonus will be based
upon the Company&#146;s assessment of your performance and the Company&#146;s attainment of written targeted goals as set by the Company in its sole discretion. Bonus payments, if any, will be subject to applicable payroll deductions and
withholdings. Following the close of each calendar year, the Board (as defined below) will determine whether you have earned an Annual Bonus, and the amount of any such bonus, based on the achievement of such goals. No amount of Annual Bonus is
guaranteed, and you must be an employee on the Annual Bonus payment date to be eligible to receive an Annual Bonus. The Annual Bonus, if earned, will be paid no later than March&nbsp;15 of the calendar year after the applicable bonus year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4.</B>&#8195;<B>Expenses. </B>The Company will reimburse you for reasonable travel, entertainment or other expenses incurred by you in furtherance or in
connection with the performance of your duties hereunder, in accordance with the Company&#146;s expense reimbursement policy as in effect from time to time. Further, the Company will reimburse up to $10,000 to you for reasonable, documented
professional fees for the review of this Agreement, and any other documents reasonably related to this offer of employment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5.</B>&#8195;<B>Equity
Compensation.</B> Subject to approval by the Company&#146;s Board of Directors or its Compensation Committee (the &#147;<B>Board</B>&#148;), the Company will grant you an option to purchase 160,000 shares of the Company&#146;s Class&nbsp;A Common
Stock with a per share exercise price equal to the fair market value of one share of Class&nbsp;A Common Stock on the applicable date of the grant (the &#147;<B>Option</B>&#148;). The Option will be subject to the terms of the Company&#146;s
then-effective equity incentive plan (the &#147;<B>Plan</B>&#148;) and your stock option agreement. The Option will vest subject to your continued employment over a four-year period, whereby 25% of your Option shares will vest on the first
anniversary of your Start Date, with the remaining shares subject to the Option vesting in 36 equal monthly installments thereafter, in each case subject to your continued employment through the applicable vesting dates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6.</B>&#8195;<B>Compliance with Confidentiality Information Agreement and Company Policies.</B> As a condition of employment, you agree to sign and comply
with the Company&#146;s Employee Confidential Information and Inventions Assignment Agreement (the &#147;<B>Confidentiality Agreement</B>&#148;), attached hereto as <B><I>Exhibit A</I></B>. In addition, you are required to abide by the
Company&#146;s policies and procedures, as modified from time to time within the Company&#146;s discretion, and acknowledge in writing that you have read and will comply with the Company&#146;s Employee Handbook (and provide additional such
acknowledgements as the Employee Handbook may be modified from time to time); provided, however, that in the event the terms of this Agreement differ from or are in conflict with the Company&#146;s general employment policies or practices, this
Agreement shall control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7.</B>&#8195;<B>Protection of Third Party Information.</B> In your work for the Company, you will be expected not to make any
unauthorized use or disclosure of any confidential or proprietary information, including trade secrets, of any former employer or other third party to whom you have contractual obligations to protect such information. Rather, you will be expected to
use only that information which is generally known and used by persons with training and experience comparable to your own, which is common knowledge in the industry or otherwise legally in the public domain, or which is otherwise provided or
developed by the Company. You represent that you are able to perform your job duties within these guidelines, and you are not in unauthorized possession of any unpublished documents, materials, electronically recorded information, or other property
belonging to any former employer or other third party to whom you have a contractual obligation to protect such property. In addition, you represent and warrant that your employment by the Company will not conflict with any prior employment or
consulting agreement or other agreement with any third party, that you will perform your duties to the Company without violating any such agreement(s), and that you have disclosed to the Company in writing any contract you have signed that may
restrict your activities on behalf of the Company. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 3
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8.</B>&#8195;<B><FONT STYLE="white-space:nowrap">At-Will</FONT> Employment Relationship.</B> Your
employment relationship with the Company is <FONT STYLE="white-space:nowrap">at-will.</FONT> Accordingly, you may terminate your employment with the Company at any time and for any reason whatsoever simply by notifying the Company; and the Company
may terminate your employment at any time, with or without Cause or advance notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9.</B>&#8195;<B>Severance Absent a Change in Control.</B> If
(x)&nbsp;the Company terminates your employment without Cause (other than as a result of your death or disability) or (y)&nbsp;you resign your employment with the Company for Good Reason (such terminations in &#147;x&#148; and &#147;y&#148; referred
to as a &#147;<B>Qualifying Termination</B>&#148;), provided such termination or resignation constitutes a Separation from Service (as defined under Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(h),</FONT> without regard
to any alternative definition thereunder, a &#147;<B>Separation from Service</B>&#148;), then subject to Sections 11, 13 and 14 below and your continued compliance with the terms of this Agreement (including without limitation Section&nbsp;6 above),
the Company will provide you with the following severance benefits (the &#147;<B><FONT STYLE="white-space:nowrap">Non-CIC</FONT> Severance Benefits</B>&#148;): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&#8195;<B>Cash Severance.</B> The Company will pay you, as cash severance, nine months of your base salary in effect as of your
Separation from Service Date, less standard payroll deductions and tax withholdings (the &#147;<B>Severance</B>&#148;). The Severance will be paid in installments on the Company&#146;s ordinary payroll dates, commencing on the Company&#146;s first
regular payroll date that is not more than 30 days following your Separation from Service Date, provided the Release (as defined below) has become effective by such date, and shall be for any accrued base salary for the <FONT
STYLE="white-space:nowrap">30-day</FONT> period plus the period from the 30<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day until the regular payroll date, if applicable, and all salary continuation payments thereafter, if any, shall be
made in equal installments on the Company&#146;s regular payroll dates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&#8195;<B>COBRA Severance. </B>As an additional
severance benefit, the Company will continue to pay the cost of your and your dependents&#146; health care coverage in effect at the time of your Separation from Service for a maximum of nine months, either under the Company&#146;s regular health
plan (if permitted), or by reimbursing for or paying your and your dependents&#146; COBRA premiums (the &#147;<B>COBRA Severance</B>&#148;). The Company&#146;s obligation to pay the COBRA Severance on your behalf will cease if you obtain health care
coverage from another source (e.g., a new employer or spouse&#146;s benefit plan), unless otherwise prohibited by applicable law. You must notify the Company within two weeks if you obtain coverage from a new source. This payment of COBRA Severance
by the Company would not expand or extend the maximum period of COBRA coverage to which you would otherwise be entitled under applicable law. Notwithstanding the above, if the Company determines in its sole discretion that it cannot provide the
foregoing COBRA Severance without potentially violating applicable law (including, without limitation, Section&nbsp;2716 of the Public Health Service Act), the Company shall in lieu thereof provide to you a taxable monthly payment in an amount equal
to the monthly COBRA premium that you would be required to pay to continue your and your dependents&#146; group health coverage in effect on the date of your termination (which amount shall be based on the premium for the first month of COBRA
coverage), which payments shall be made on the last day of each month regardless of whether you elect COBRA continuation coverage and shall end on the earlier of (x)&nbsp;the date upon which you and your dependents obtain other coverage and
(y)&nbsp;the last day of the ninth calendar month following your Separation from Service Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10.</B>&#8195;<B>Change in Control Severance.</B> In
the event of a Qualifying Termination that occurs within three months prior to or within twelve months following the closing of a Change in Control (as defined below), provided such Qualifying Termination constitutes a Separation from Service, then
subject to Sections 11, 13 and 14 below and your continued compliance with the terms of this Agreement (including without limitation Section&nbsp;6 above), the Company will (a)&nbsp;accelerate the vesting of any of your then-unvested equity in the
Company such that 100% of such equity shall be deemed immediately vested and exercisable as of your Separation from Service Date; and (b)&nbsp;increase the amount of Severance described in Section&nbsp;9(a) and COBRA Severance described in
Section&nbsp;9(b) </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 4
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to twelve months, and add to the cash component, as an additional severance benefit, an amount equal to your target Annual Bonus for the year of your Qualifying Termination, with such cash
component to be paid in a single lump sum within ten business days after the effective date of the Release (the &#147;<B>CIC Severance Benefits</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11.</B>&#8195;<B>Limitation on Severance Benefits / Clawback and Recovery.</B> Under no circumstances will you be able to receive both the <FONT
STYLE="white-space:nowrap">Non-CIC</FONT> Severance Benefits and the CIC Severance Benefits. Any and all <FONT STYLE="white-space:nowrap">Non-CIC</FONT> Severance Benefits and CIC Severance Benefits provided under this Agreement will be subject to
recoupment in accordance with the Company&#146;s Incentive Compensation Recoupment Policy, as the same may be amended or restated from time to time, and any other clawback policy that the Company adopts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12.</B>&#8195;<B>Termination for Cause; Resignation Without Good Reason; Death or Disability.</B> If at any time (a)&nbsp;the Company terminates your
employment for Cause, (b)&nbsp;you resign your employment without Good Reason, or (c)&nbsp;either party terminates your employment as a result of your death or disability, then in any such case you will receive only your base salary accrued through
your last day of employment, as well as any unused vacation (if applicable) accrued through your last day of employment. Under these circumstances, you will not be entitled to any other form of compensation from the Company, including the <FONT
STYLE="white-space:nowrap">Non-CIC</FONT> Severance Benefits, the CIC Severance Benefits, or any other severance benefits, other than your rights to the vested portion of any equity and any other rights to which you are entitled under the
Company&#146;s benefit programs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13.</B>&#8195;<B>Conditions to Receipt of the <FONT STYLE="white-space:nowrap">Non-CIC</FONT> Severance Benefits and
CIC Severance Benefits.</B> Prior to and as a condition to your receipt of the <FONT STYLE="white-space:nowrap">Non-CIC</FONT> Severance Benefits or CIC Severance Benefits described above, you shall execute and deliver to the Company an effective
release of claims in favor of the Company and substantially in the form attached as <B><I>Exhibit A</I></B> to this Agreement (the &#147;<B>Release</B>&#148;) (which will include a <FONT STYLE="white-space:nowrap">non-disparagement</FONT> covenant
in favor of the Company) within the applicable timeframe set forth therein, but not later than 21 days following your Separation from Service Date, and allow the Release to become effective according to its terms (by not invoking any legal right to
revoke it) within any applicable time period set forth therein (such latest permitted effective date, the &#147;<B>Release Deadline</B>&#148;). The Release may be modified as required to conform to state-specific requirements, multiple-person
terminations and/or changes in applicable state or federal law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14.</B>&#8195;<B>Return of Company Property.</B> Within five business days after your
Separation from Service Date (or earlier if requested by the Company), you will return to the Company all Company documents (and all copies thereof) and other Company property within your possession, custody or control, including, but not limited
to, Company files, notes, financial and operational information, customer lists and contact information, product and services information, research and development information, Company account and device login and password information, drawings,
records, plans, forecasts, reports, payroll information, spreadsheets, studies, analyses, compilations of data, proposals, agreements, sales and marketing information, personnel information, specifications, code, software, databases,
computer-recorded information, tangible property and equipment (including, but not limited to, computers, facsimile machines, mobile telephones, tablets, handheld devices, and servers), credit cards, entry cards, identification badges and keys, and
any materials of any kind which contain or embody any proprietary or confidential information of the Company, and all reproductions thereof in whole or in part and in any medium. You further agree that you will make a diligent search to locate any
such documents, property and information and return them to the Company within the timeframe provided above. In addition, if you have used any personally-owned computer, server, or <FONT STYLE="white-space:nowrap">e-mail</FONT> system to receive,
store, review, prepare or transmit any confidential or proprietary data, materials or information of the Company, then within five business days after your Separation from Service Date you will make best efforts to permanently delete and expunge
such confidential or proprietary information from those systems without retaining any reproductions (in whole or in part). You shall deliver to the Company a signed statement certifying compliance with this Section&nbsp;14 prior to the receipt of
the <FONT STYLE="white-space:nowrap">Non-CIC</FONT> Severance Benefits or CIC Severance Benefits. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 5
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>15.</B>&#8195;<B>Outside Activities.</B> Throughout your employment with the Company, you may engage in
civic and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">not-for-profit</FONT></FONT> activities so long as such activities do not interfere with the performance of your duties hereunder or present a conflict of interest with the
Company. Subject to the restrictions set forth herein and with the prior written consent of the Company, you may serve as a director of other corporations and may devote a reasonable amount of your time to other types of business or public
activities not expressly mentioned in this paragraph. The Company may rescind its consent to your service as a director of all other corporations or participation in other business or public activities, if the Company, in its sole discretion,
determines that such activities compromise or threaten to compromise the Company&#146;s business interests or conflict with your duties to the Company.<B> </B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During your employment by the Company, except on behalf of the Company, you will not directly or indirectly serve as an officer, director, stockholder,
employee, partner, proprietor, investor, joint venturer, associate, representative or consultant of any other person, corporation, firm, partnership or other entity whatsoever known by you to compete with the Company (or is planning or preparing to
compete with the Company), anywhere in the world, in any line of business engaged in (or planned to be engaged in) by the Company; provided, however, that you may purchase or otherwise acquire up to (but not more than) 1% of any class of securities
of any enterprise (but without participating in the activities of such enterprise) if such securities are listed on any national or regional securities exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>16.</B>&#8195;<B>Definitions.</B> For purposes of this Agreement, the following terms shall have the following meanings: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this Agreement, &#147;<B>Cause</B>&#148; for termination will mean your: (a)&nbsp;commission or conviction (including a guilty plea or plea of
nolo contendere) of any felony or any other crime involving fraud, dishonesty or moral turpitude; (b)&nbsp;your commission or attempted commission of or participation in a fraud or act of dishonesty or misrepresentation against the Company;
(c)&nbsp;material breach of your duties to the Company; (d)&nbsp;intentional damage to any property of the Company; (e)&nbsp;misconduct, or other violation of any Company policy that causes material harm; provided that the parties cannot agree in
good faith to a reasonable cure of such misconduct or violation; (f)&nbsp;your material violation of any written and fully executed contract or agreement between you and the Company, including without limitation, material breach of your
Confidentiality Agreement, or of any statutory duty you owe to the Company; or (g)&nbsp;conduct by you which in the good faith and reasonable determination of the Company demonstrates gross unfitness to serve. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this Agreement, you shall have &#147;<B>Good Reason</B>&#148; for resigning from employment with the Company if any of the following actions
are taken by the Company without your prior written consent: (a)&nbsp;a&nbsp;material reduction in your base salary, which the parties agree is a reduction of at least 10% of your base salary (unless pursuant to a salary reduction program applicable
generally to the Company&#146;s similarly situated employees); (b) a material reduction in your duties (including responsibilities and/or authorities, change of title, and/or, except in the case of a material change to the Company, reporting
structure), <I>provided, however</I>, that a change in job position shall not be deemed a &#147;material reduction&#148; in and of itself unless your new duties are materially reduced from the prior duties; or (c)&nbsp;relocation of your principal
place of employment to a place that increases your <FONT STYLE="white-space:nowrap">one-way</FONT> commute by more than 50 miles as compared to your then-current principal place of employment immediately prior to such relocation, <I>provided</I>
that if you work remotely during any period in which your regular principal place of employment at a Company office is closed, then neither your relocation to remote work or back to the office from remote work will be considered a relocation of your
principal place of employment with the Company for purposes of this definition. In order to resign for Good Reason, you must provide written notice to the Chief Executive Officer or the Board within 30 days after each occurrence of the event giving
rise to Good Reason setting forth the basis for your resignation, allow the Company at least 30 days from receipt of such written notice to cure such event, and if such event is not reasonably cured within such period, you must resign from all
positions you then hold with the Company not later than 30 days after the expiration of the cure period. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 6
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this Agreement, &#147;<B>Change in Control</B>&#148; shall mean: (a)&nbsp;any consolidation
or merger of the Company with or into any other corporation or other entity or person, or any other corporate reorganization, other than any such consolidation, merger or reorganization in which the stockholders of the Company immediately prior to
such consolidation, merger or reorganization, continue to hold a majority of the voting power of the surviving entity (or, if the surviving entity is a wholly owned subsidiary, its parent) immediately after such consolidation, merger or
reorganization; (b)&nbsp;any transaction or series of related transactions to which the Company is a party in which in excess of 50% of the Company&#146;s voting power is transferred; <I>provided</I> that the foregoing shall not include any
transaction or series of transactions principally for bona fide equity financing purposes in which cash is received by the Company or indebtedness of the Company is cancelled or converted or a combination thereof; or (c)&nbsp;a sale, lease,
exclusive license or other disposition of all or substantially all of the assets of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>17.</B>&#8195;<B>Compliance with
Section</B><B></B><B>&nbsp;409A.</B> It is intended that the <FONT STYLE="white-space:nowrap">Non-CIC</FONT> Severance Benefits and CIC Severance Benefits set forth in this Agreement satisfy, to the greatest extent possible, the exemptions from the
application of Section&nbsp;409A of the Internal Revenue Code of 1986, as amended, (the &#147;<B>Code</B>&#148;) (Section 409A, together with any state law of similar effect, &#147;<B>Section</B><B></B><B>&nbsp;409A</B>&#148;) provided under
Treasury Regulations <FONT STYLE="white-space:nowrap">1.409A-1(b)(4),</FONT> <FONT STYLE="white-space:nowrap">1.409A-1(b)(5)</FONT> and <FONT STYLE="white-space:nowrap">1.409A-1(b)(9).</FONT> For purposes of Section&nbsp;409A (including, without
limitation, for purposes of Treasury Regulations <FONT STYLE="white-space:nowrap">1.409A-2(b)(2)(iii)),</FONT> your right to receive any installment payments under this Agreement (whether severance payments, reimbursements or otherwise) shall be
treated as a right to receive a series of separate payments and, accordingly, each installment payment hereunder shall at all times be considered a separate and distinct payment. Notwithstanding any provision to the contrary in this Agreement, if
the Company (or, if applicable, the successor entity thereto) determines that the <FONT STYLE="white-space:nowrap">Non-CIC</FONT> Severance Benefits or CIC Severance Benefits constitute &#147;deferred compensation&#148; under Section&nbsp;409A and
you are, on the date of your Qualifying Termination, a &#147;specified employee&#148; of the Company or any successor entity thereto, as such term is defined in Section&nbsp;409A(a)(2)(B)(i) of the Code (a &#147;<B>Specified Employee</B>&#148;),
then, solely to the extent necessary to avoid the incurrence of adverse personal tax consequences under Section&nbsp;409A, the timing of the <FONT STYLE="white-space:nowrap">Non-CIC</FONT> Severance Benefits or CIC Severance Benefits shall be
delayed until the earliest of: (i)&nbsp;the date that is six months and one day after your Qualifying Termination date, (ii)&nbsp;the date of your death, or (iii)&nbsp;such earlier date as permitted under Section&nbsp;409A without the imposition of
adverse taxation. Upon the first business day following the expiration of such applicable Code Section&nbsp;409A(a)(2)(B)(i) period, all payments or benefits deferred pursuant to this section shall be paid in a lump sum or provided in full by the
Company (or the successor entity thereto, as applicable), and any remaining payments due shall be paid as otherwise provided herein. No interest shall be due on any amounts so deferred. If the <FONT STYLE="white-space:nowrap">Non-CIC</FONT>
Severance Benefits or CIC Severance Benefits are not covered by one or more exemptions from the application of Section&nbsp;409A and the Release could become effective in the calendar year following the calendar year in which you have a Qualifying
Termination, the Release will not be deemed effective any earlier than the Release Deadline. The <FONT STYLE="white-space:nowrap">Non-CIC</FONT> Severance Benefits and CIC Severance Benefits are intended to qualify for an exemption from application
of Section&nbsp;409A or comply with its requirements to the extent necessary to avoid adverse personal tax consequences under Section&nbsp;409A, and any ambiguities herein shall be interpreted accordingly. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>18.&#8195;Section 280G; Parachute Payments. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&#8195;If any payment or benefit you will or may receive from the Company or otherwise (a &#147;<B>280G Payment</B>&#148;) would
(1)&nbsp;constitute a &#147;parachute payment&#148; within the meaning of Section&nbsp;280G of the Code, and (2)&nbsp;but for this sentence, be subject to the excise tax imposed by Section&nbsp;4999 of the Code (the &#147;<B>Excise Tax</B>&#148;),
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 7
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
then any such 280G Payment provided pursuant to this Agreement (a &#147;<B>Payment</B>&#148;) shall be equal to the Reduced Amount. The &#147;Reduced Amount&#148; shall be either (x)&nbsp;the
largest portion of the Payment that would result in no portion of the Payment (after reduction) being subject to the Excise Tax or (y)&nbsp;the largest portion, up to and including the total, of the Payment, whichever amount (i.e., the amount
determined by clause (x)&nbsp;or by clause (y)), after taking into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results in your receipt, on
an <FONT STYLE="white-space:nowrap">after-tax</FONT> basis, of the greater economic benefit notwithstanding that all or some portion of the Payment may be subject to the Excise Tax. If a reduction in a Payment is required pursuant to the preceding
sentence and the Reduced Amount is determined pursuant to clause (x)&nbsp;of the preceding sentence, the reduction shall occur in the manner (the &#147;<B>Reduction Method</B>&#148;) that results in the greatest economic benefit for you. If more
than one method of reduction will result in the same economic benefit, the items so reduced will be reduced pro rata (the &#147;<B>Pro Rata Reduction Method</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&#8195;Notwithstanding any provision of subsection (a)&nbsp;above to the contrary, if the Reduction Method or the Pro Rata Reduction
Method would result in any portion of the Payment being subject to taxes pursuant to Section&nbsp;409A that would not otherwise be subject to taxes pursuant to Section&nbsp;409A, then the Reduction Method and/or the Pro Rata Reduction Method, as the
case may be, shall be modified so as to avoid the imposition of taxes pursuant to Section&nbsp;409A as follows: (1)&nbsp;as a first priority, the modification shall preserve to the greatest extent possible, the greatest economic benefit for you as
determined on an <FONT STYLE="white-space:nowrap">after-tax</FONT> basis; (2)&nbsp;as a second priority, Payments that are contingent on future events (e.g., being terminated without Cause), shall be reduced (or eliminated) before Payments that are
not contingent on future events; and (3)&nbsp;as a third priority, Payments that are &#147;deferred compensation&#148; within the meaning of Section&nbsp;409A shall be reduced (or eliminated) before Payments that are not deferred compensation within
the meaning of Section&nbsp;409A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B>&#8195;Unless you and the Company agree on an alternative accounting firm or law firm, the
accounting firm engaged by the Company for general tax compliance purposes as of the day prior to the effective date of the change in control transaction shall perform the foregoing calculations. If the accounting firm so engaged by the Company is
serving as accountant or auditor for the individual, entity or group effecting the change in control transaction, the Company shall appoint a nationally recognized accounting or law firm to make the determinations required by this Section&nbsp;18.
The Company shall bear all expenses with respect to the determinations by such accounting or law firm required to be made hereunder. The Company shall use commercially reasonable efforts to cause the accounting or law firm engaged to make the
determinations hereunder to provide its calculations, together with detailed supporting documentation, to you and the Company within 15 calendar days after the date on which your right to a 280G Payment becomes reasonably likely to occur (if
requested at that time by you or the Company) or such other time as requested by you or the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B>&#8195;If you receive a
Payment for which the Reduced Amount was determined pursuant to clause (x)&nbsp;of Section&nbsp;18(a) and the Internal Revenue Service determines thereafter that some portion of the Payment is subject to the Excise Tax, Executive agrees to promptly
return to the Company a sufficient amount of the Payment (after reduction pursuant to clause (x)&nbsp;of Section&nbsp;18(a)) so that no portion of the remaining Payment is subject to the Excise Tax. For the avoidance of doubt, if the Reduced Amount
was determined pursuant to clause (y)&nbsp;of Section&nbsp;18(a), you shall have no obligation to return any portion of the Payment pursuant to the preceding sentence. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>19.</B>&#8195;<B>Dispute Resolution.</B> To ensure the rapid and economical resolution of disputes that may arise in connection with your employment with
the Company, and in exchange for the mutual promises contained in this offer letter, you and the Company agree that any and all disputes, claims, or causes of action, in law or equity, including but not limited to statutory claims, arising from or
relating to the enforcement, breach, performance, or </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 8
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
interpretation of this letter agreement, your employment with the Company, or the termination of your employment, shall be resolved pursuant to the Federal Arbitration Act, 9 U.S.C. &#167; <FONT
STYLE="white-space:nowrap">1-16,</FONT> to the fullest extent permitted by law, by final, binding and confidential arbitration conducted by JAMS or its successor, under JAMS&#146; then applicable rules and procedures appropriate to the relief being
sought (available upon request and also currently available at the following web address(es): (i) <U>https://www.jamsadr.com/rules-employment-arbitration/</U> and (ii)&nbsp;<U>https://www.jamsadr.com/rules-comprehensive-arbitration/</U>) at a
location closest to where you last worked for the Company or another mutually agreeable location. <B>You acknowledge that by agreeing to this arbitration procedure, both you and the Company waive the right to resolve any such dispute through a trial
by jury or judge.</B> This provision shall not be mandatory for any claim or cause of action to the extent applicable law prohibits subjecting such claim or cause of action to mandatory arbitration and such applicable law is not preempted by the
Federal Arbitration Act or otherwise invalid (collectively, the &#147;<B>Excluded Claims</B>&#148;), including claims or causes of action alleging sexual harassment or a nonconsensual sexual act or sexual contact, or unemployment or workers&#146;
compensation claims brought before the applicable state governmental agency. In the event you or the Company intend to bring multiple claims, including one of the Excluded Claims listed above, the Excluded Claims may be filed with a court, while any
other claims will remain subject to mandatory arbitration. Nothing herein prevents you from filing and pursuing proceedings before a federal or state governmental agency, although if you choose to pursue a claim following the exhaustion of any
applicable administrative remedies, that claim would be subject to this provision. In addition, with the exception of Excluded Claims arising out of 9 U.S.C., chapter 4, all claims, disputes, or causes of action under this section, whether by you or
the Company, must be brought in an individual capacity, and shall not be brought as a plaintiff (or claimant) or class member in any purported class or representative proceeding, nor joined or consolidated with the claims of any other person or
entity. The arbitrator may not consolidate the claims of more than one person or entity, and may not preside over any form of representative or class proceeding. To the extent that the preceding sentences regarding class or representative claims or
proceedings are found to violate applicable law or are otherwise found unenforceable, any claim(s) alleged or brought on behalf of a class or in a representative capacity shall proceed in a court of law rather than by arbitration. You will have the
right to be represented by legal counsel at any arbitration proceeding. Questions of whether a claim is subject to arbitration under this agreement shall be decided by the arbitrator, unless applicable law provides otherwise. Likewise, procedural
questions which grow out of the dispute and bear on the final disposition are also matters for the arbitrator, provided however, that if required by applicable law, a court and not the arbitrator may determine the enforceability of this paragraph
with respect to Excluded Claims. The arbitrator shall: (a)&nbsp;have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (b)&nbsp;issue a written statement
signed by the arbitrator regarding the disposition of each claim and the relief, if any, awarded as to each claim, the reasons for the award, and the arbitrator&#146;s essential findings and conclusions on which the award is based. The arbitrator
shall be authorized to award all relief that you or the Company would be entitled to seek in a court of law. The Company shall pay all arbitration administrative fees in excess of the administrative fees that you would be required to pay if the
dispute were decided in a court of law. Each party is responsible for its own attorneys&#146; fees, except as may be expressly set forth in your employee confidential information and inventions assignment agreement or as otherwise provided under
applicable law. Nothing in this letter agreement is intended to prevent either you or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration. Any awards or orders in such
arbitrations may be entered and enforced as judgments in the federal and state courts of any competent jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>20.</B>&#8195;<B>Miscellaneous.</B> This offer is contingent upon a background check clearance, reference checks clearance, and satisfactory proof of your
identity and right to work in the United States. This Agreement, together with your Confidentiality Agreement, forms the complete and exclusive statement of your employment agreement with the Company. It supersedes any other agreements or promises
made to you by anyone, whether oral or written. Changes in your employment terms, other than those changes expressly reserved to the Company&#146;s or Board&#146;s </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 9
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
discretion in this Agreement, require a written modification approved by the Company and signed by a duly authorized officer of the Company. This Agreement will bind the heirs, personal
representatives, successors and assigns of both you and the Company, and inure to the benefit of both you and the Company, their heirs, successors and assigns. If any provision of this Agreement is determined to be invalid or unenforceable, in whole
or in part, this determination shall not affect any other provision of this Agreement and the provision in question shall be modified so as to be rendered enforceable in a manner consistent with the intent of the parties insofar as possible under
applicable law. This Agreement shall be construed and enforced in accordance with the laws of the State of California without regard to conflicts of law principles. Any ambiguity in this Agreement shall not be construed against either party as the
drafter. Any waiver of a breach of this Agreement, or rights hereunder, shall be in writing and shall not be deemed to be a waiver of any successive breach or rights hereunder. This Agreement may be delivered via facsimile, electronic mail
(including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law (e.g., www.docusign.com)) or other transmission method and shall be deemed to have been duly
and validly delivered and be valid and effective for all purposes, and may be executed in counterparts which shall be deemed to be part of one original, and facsimile and electronic signatures shall be equivalent to original signatures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please sign and date this Agreement and the enclosed Confidentiality Agreement and return them to me on or before June&nbsp;25, 2024 if you wish to accept
employment at the Company under the terms described above. The offer of employment herein will expire if I do not receive this signed letter by that date. I would be happy to discuss any questions that you may have about these terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are delighted to be making this offer and the Company looks forward to your favorable reply and to a productive and enjoyable work relationship. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Marshall W. Fordyce, M.D.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Marshall W. Fordyce, M.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chief Executive Officer</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Reviewed, Understood, and Accepted: </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Johnson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">June&nbsp;26, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">David Johnson</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Exhibit A: Employee Confidential Information and Inventions Assignment Agreement </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Exhibit B: Form of Release </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 10.1 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g799103g0702111704948.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>E<SMALL>XHIBIT</SMALL> A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>EMPLOYEE CONFIDENTIAL INFORMATION AND INVENTIONS ASSIGNMENT AGREEMENT </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EMPLOYEE CONFIDENTIAL INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND INVENTIONS ASSIGNMENT AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
consideration of my employment or continued employment by Vera Therapeutics, Inc. (&#147;<B><I>E</I></B><B><I>mployer</I></B>&#148;), and its subsidiaries, parents, affiliates, successors, and assigns (together with Employer,
&#147;<B><I>Company</I></B>&#148;), the compensation paid to me now and during my employment with Company, and Company&#146;s agreement to provide me with access to its Confidential Information (as defined below), I enter into this Employee
Confidential Information and Inventions Assignment Agreement with Employer (the &#147;<B><I>Agreement</I></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. During the
course of my employment, I will have access to and knowledge of Company&#146;s trade secrets and Confidential Information; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. It is
of material benefit to restrict the disclosure of Company&#146;s trade secrets and Confidential Information with a nondisclosure, <FONT STYLE="white-space:nowrap">non-competition,</FONT> and <FONT STYLE="white-space:nowrap">non-solicitation</FONT>
agreement, all of which are reasonable in terms of scope, geography and duration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accordingly, in consideration of the mutual promises
and covenants contained herein, Employer (on behalf of itself and Company) and I agree as follows: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Confidential Information Protections</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Recognition of Company</B><B>&#146;</B><B>s Rights; Nondisclosure</B>. My employment by Company creates a relationship of confidence and
trust with respect to Confidential Information (as defined below) and Company has a protectable interest in the Confidential Information. Except to the extent permitted by Section&nbsp;13.12, at all times during and after my employment, I will hold
in confidence and will not disclose, use, lecture upon, or publish any Confidential Information, except as required in connection with my work for Company, or as approved by an officer of Company. I will obtain written approval by an officer of
Company before I lecture on or submit for publication any material (written, oral, or otherwise) that discloses and/or incorporates any Confidential Information. I will take all reasonable precautions to prevent the disclosure of Confidential
Information. Notwithstanding the foregoing, pursuant to 18 U.S.C. Section&nbsp;1833(b), I will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (1)&nbsp;is made in
confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law; or (2)&nbsp;is made in a complaint or other
document filed in a lawsuit or other proceeding, if such filing is made under seal. Company information or documentation to which I have access during my employment, regardless of whether it contains Confidential Information, is the property of
Company and cannot be downloaded or retained for my personal use or for any use that is outside the scope of my duties for Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Confidential Information</B>. &#147;<B><I>Confidential Information</I></B>&#148; means any and all confidential knowledge or data of
Company, and includes any confidential knowledge or data that Company has received, or receives in the future, from third parties that Company has agreed to treat as confidential and to use for only certain limited purposes. By way of illustration
but not limitation, Confidential Information includes (a)&nbsp;trade secrets, inventions, ideas, processes, formulas, software in source or object code, data, technology, <FONT STYLE="white-space:nowrap">know-how,</FONT> designs and techniques, and
any other work product of any nature, and all Intellectual Property Rights (defined below) in all of the foregoing (collectively, &#147;<B><I>Inventions</I></B>&#148;), including all Company Inventions (defined in Section&nbsp;2.1);
(b)&nbsp;information regarding research, development, new products, business and operational plans, budgets, unpublished financial statements and projections, costs, margins, discounts, credit terms, pricing, quoting procedures, future plans and
strategies, capital-raising plans, internal services, suppliers and supplier information; (c)&nbsp;information about customers and potential customers of Company, including customer lists, </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 2 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
names, representatives, their needs or desires with respect to the types of products or services offered by Company, and other <FONT STYLE="white-space:nowrap">non-public</FONT> information;
(d)&nbsp;information about Company&#146;s business partners and their services, including names, representatives, proposals, bids, contracts, and the products and services they provide; (e)&nbsp;information regarding personnel, employee lists,
compensation, and employee skills; and (f)&nbsp;any other <FONT STYLE="white-space:nowrap">non-public</FONT> information that a competitor of Company could use to Company&#146;s competitive disadvantage. However, Company agrees that I am free to use
information that I knew before my employment with Company or that is, at the time of use, generally known in the trade or industry through no breach of this Agreement by me. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Third Party Information</B>. I understand, in addition, that Company has received and in the future will receive from third parties their
confidential and/or proprietary knowledge, data or information (<B>&#147;</B><B><I>Third Party Information</I></B><B>&#148;</B>) subject to a duty on Company&#146;s part to maintain the confidentiality of such information and to use it only for
certain limited purposes. During my employment and thereafter, I will hold Third Party Information in confidence and will not disclose to anyone (other than Company personnel who need to know such information in connection with their work for
Company) or use, except in connection with my work for Company, Third Party Information unless expressly authorized by an officer of Company in writing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Term of Nondisclosure Restrictions</B>. Except to the extent permitted by Section&nbsp;13.12, I will only use or disclose Confidential
Information and Third Party Information as provided in this Section&nbsp;1. The restrictions in this Section&nbsp;1 are intended to and will continue indefinitely, even after my employment by Company ends. However, if a time limitation on my
obligation not to use or disclose Confidential Information and Third Party Information is required under applicable law, and the Agreement or its restriction(s) cannot otherwise be enforced, the <FONT STYLE="white-space:nowrap">two-year</FONT>
period after the date my employment ends will be the time limitation relevant to the contested restriction; <B><I>provided, however</I></B>, that my obligation not to disclose or use trade secrets that are protected without time limitation under
applicable law will continue indefinitely. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>No Improper Use of Information of Prior Employers and Others</B>. During my employment by
Company, I will not improperly use or disclose confidential information or trade secrets, if any, of any former employer or any other person to whom I have an obligation of confidentiality, and I will not bring onto Company&#146;s premises any
unpublished documents or property belonging to a former employer or any other person to whom I have an obligation of confidentiality unless that former employer or person has consented in writing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Restricted Access Granted. </B>In exchange for my agreement not to disclose or use Confidential Information or Third Party Information,
except as required in performing my duties for Company, and for the <FONT STYLE="white-space:nowrap">non-solicitation</FONT> covenants, and the other promises provided herein, Company will grant me access to Confidential Information or Third Party
Information required to fulfill the duties of my position as determined by Company. I agree that Company has no <FONT STYLE="white-space:nowrap">pre-existing</FONT> obligation to reveal Confidential Information or Third Party Information. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Assignments of Inventions. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Definitions</B>. The term (a)<B>&nbsp;&#147;</B><B><I>Intellectual Property Rights</I></B><B>&#148;</B> means all past, present and future
rights of the following types, which may exist or be created under the laws of any jurisdiction in the world: trade secrets, Copyrights, trademark and trade name rights, mask work rights, patents and industrial property, and all proprietary rights
in technology or works of authorship (including, in each case, any application for any such rights, all rights to priority, and any rights to apply for any such rights, as well as all rights to pursue remedies for infringement or violation of any
such rights); (b)&nbsp;&#147;<B><I>Copyright</I></B>&#148; means the exclusive legal right to reproduce, perform, display, distribute and make derivative works of a work of authorship (for example, a literary, musical, or artistic work) recognized
by the laws of any jurisdiction in the world; (c)&nbsp;&#147;<B><I>Moral Rights</I></B>&#148; means all paternity, integrity, disclosure, withdrawal, special and similar rights recognized by the laws of any jurisdiction in the world; and
(d)&nbsp;&#147;<B><I>Company Inventions</I></B>&#148; means any and all Inventions (and all Intellectual Property Rights related to Inventions) that are made, conceived, developed, prepared, produced, authored, edited, amended, reduced to practice,
or learned or set out in any tangible medium of expression or otherwise created, in whole or in part, by me, either alone or with others, during my employment by Company, and all printed, physical, and electronic copies, and other tangible
embodiments of Inventions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Employee Confidential
Information and Inventions Assignment Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page 2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 3 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-Assignable</FONT> Inventions</B>. I recognize that
this Agreement will not be deemed to require assignment of any Invention that I develop entirely on my own time without using Company&#146;s equipment, supplies, facilities or trade secrets, or Confidential Information, except for Inventions that
either (i)&nbsp;relate to Company&#146;s actual or anticipated business, research or development, or (ii)&nbsp;result from or are connected with any work performed by me for Company. In addition, this Agreement does not apply to any Invention that
qualifies fully for protection from assignment to Employer to the extent applicable to me as described in <B><U>Exhibit A</U></B> for employees working in certain jurisdictions (collectively, &#147;<B><I>Nonassignable Inventions</I></B>&#148;). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Prior Inventions</B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On the
signature page to this Agreement is a<I> </I>list describing any Inventions that (i)&nbsp;are owned by me or in which I have an interest and that were made or acquired by me before my date of first employment by Company, and (ii)&nbsp;may relate to
Company&#146;s business or actual or demonstrably anticipated research or development, and (iii)&nbsp;are not to be assigned to Company (&#147;<B><I>Prior Inventions</I></B>&#148;). If no such list is attached, I agree, represent and warrant that no
Inventions that would be classified as Prior Inventions exist as of the date of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If I use any Prior Inventions and/or
Nonassignable Inventions in the scope of my employment, or if I include any Prior Inventions and/or Nonassignable Inventions in any product or service of Company, or if my rights in any Prior Inventions and/or any Nonassignable Inventions may block
or interfere with, or may otherwise be required for, the exercise by Company of any rights assigned to Company under this Agreement (each, a &#147;<B><I>License Event</I></B>&#148;), (i)&nbsp;I will immediately notify Company in writing, and
(ii)&nbsp;unless Company and I agree otherwise in writing, I hereby grant to Company a <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> perpetual, transferable, fully-paid, royalty-free, irrevocable, worldwide license, with rights to
sublicense through multiple levels of sublicensees, to reproduce, make derivative works of, distribute, publicly perform, and publicly display in any form or medium (whether now known or later developed), make, have made, use, sell, import, offer
for sale, and exercise any and all present or future rights in, such Prior Inventions and/or Nonassignable Inventions. To the extent that any third parties have any rights in or to any Prior Inventions or any Nonassignable Inventions, I represent
and warrant that such third party or parties have validly and irrevocably granted to me the right to grant the license stated above. For purposes of this Section&nbsp;2.3(b), &#147;<B><I>Prior Inventions</I></B>&#148; includes any Inventions that
would be classified as Prior Inventions, whether or not they are listed on the signature page to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Assignment of Company
Inventions</B>. I hereby assign to Employer all my right, title, and interest in and to any and all Company Inventions other than Nonassignable Inventions and agree that such assignment includes an assignment of all Moral Rights. To the extent such
Moral Rights cannot be assigned to Employer and to the extent the following is allowed by the laws in any country where Moral Rights exist, I hereby unconditionally and irrevocably waive the enforcement of such Moral Rights, and all claims and
causes of action of any kind against Employer or related to Employer&#146;s customers, with respect to such rights. Neither my <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">successors-in-interest</FONT></FONT> nor legal heirs
retain any Moral Rights in any Company Inventions. Nothing contained in this Agreement may be construed to reduce or limit Company&#146;s rights, title, or interest in any Company Inventions so as to be less in any respect than that Company would
have had in the absence of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Obligation to Keep Company Informed</B>. During my employment by Company, I will promptly
and fully disclose to Company in writing all Inventions that I author, conceive, or reduce to practice, either alone or jointly with others. At the time of each disclosure, I will advise Company in writing of any Inventions that I believe constitute
Nonassignable Inventions; and I will at that time provide to Company in writing all evidence necessary to substantiate my belief. Subject to Section&nbsp;2.3(b), Company agrees to keep in confidence, not use for any purpose, and not disclose to
third parties without my consent, any confidential information relating to Nonassignable Inventions that I disclose in writing to Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Government or Third Party</B>. I agree that, as directed by Company, I will assign to a third party, including the United States, all my
right, title, and interest in and to any particular Company Invention. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Employee Confidential
Information and Inventions Assignment Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page 3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 4 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Ownership of Work Product</B>. I acknowledge that all original works of authorship that
are made by me (solely or jointly with others) within the scope of my employment and that are protectable by Copyright are &#147;works made for hire,&#148; pursuant to United States Copyright Act (17 U.S.C., Section&nbsp;101). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Enforcement of Intellectual Property Rights and Assistance</B>. I will assist Company, in every way Company requests, including signing,
verifying and delivering any documents and performing any other acts, to obtain and enforce United States and foreign Intellectual Property Rights and Moral Rights relating to Company Inventions in any jurisdictions in the world. My obligation to
assist Company with respect to Intellectual Property Rights relating to Company Inventions will continue beyond the termination of my employment, but Company will compensate me at a reasonable rate after such termination for the time I actually
spend on such assistance. If Company is unable for any reason, after reasonable effort, to secure my signature on any document needed in connection with the actions specified in this paragraph, I hereby irrevocably designate and appoint Employer and
its duly authorized officers and agents as my agent and attorney in fact, which appointment is coupled with an interest, to act for and on my behalf to execute, verify and file any such documents and to do all other lawfully permitted acts to
further the purposes of this Agreement with the same legal force and effect as if executed by me. I hereby waive and quitclaim to Company any and all claims, of any nature whatsoever, which I now or may hereafter have for infringement of any
Intellectual Property Rights assigned to Employer under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Incorporation of Software Code</B>. I will not incorporate
into any Inventions, including any Company software, or otherwise deliver to Company, any software code licensed under the GNU General Public License, Lesser General Public License, or any other license that, by its terms, requires or conditions the
use or distribution of such code on the disclosure, licensing, or distribution of any source code owned or licensed by Company, <B>except</B> in strict compliance with Company&#146;s policies regarding the use of such software or as specifically
directed by Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Records</B>. I will keep and maintain adequate and current records (in the form of notes, sketches, drawings and in any other
form that is required by Company) of all Confidential Information developed by me and all Company Inventions made by me during the period of my employment at Company, which records will be available to and remain the sole property of Employer at all
times. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Duty of Loyalty During Employment</B>. To the extent applicable to me or modified for me as described in
<B><U>Exhibit</U></B><B><U></U></B><B><U>&nbsp;B</U></B> based on the jurisdiction in which I work, during my employment by Company, I will not, without Company&#146;s written consent, directly or indirectly engage in any employment or business
activity that is directly or indirectly competitive with, or would otherwise conflict with, my employment by Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Solicitation of Employees,
Consultants, Contractors, or Customers or Potential Customers</B>. To the extent applicable to me or modified for me as described in <B><U>Exhibit C</U></B> based on the jurisdiction in which I work, and subject to future modification by
Section&nbsp;10.3, during the period of my employment and for the <FONT STYLE="white-space:nowrap">one-year</FONT> period after the date my employment ends for any reason, including voluntary termination by me or involuntary termination by Company,
I will not, as an officer, director, employee, consultant, owner, partner, or in any other capacity, either directly or through others, except on behalf of Company: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">solicit, induce, encourage, or participate in soliciting, inducing or encouraging any person then employed by Company or who has left the
employment of Company within the preceding six months, or any person or entity engaged by Company as a consultant or independent contractor or who/which has ceased a service relationship with Company within the preceding six months, to terminate
such person&#146;s or entity&#146;s relationship with Company, even if I did not initiate the discussion or seek out the contact; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">solicit, induce, encourage, or participate in soliciting, inducing, or encouraging any person then employed by Company or who has left the
employment of Company within the preceding six months, or any person or entity engaged by Company as a consultant or independent contractor or who/which has ceased a service relationship with Company
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Employee Confidential
Information and Inventions Assignment Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page 4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 5 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
within the preceding six months, to terminate such person&#146;s or entity&#146;s relationship with Company to render services to me or any other person or entity that researches, develops,
markets, sells, performs or provides or is preparing to develop, market, sell, perform or provide Conflicting Services (as defined below); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">hire or attempt to hire any person who is an employee, consultant, or independent contractor of Company, even if I did not initiate the
discussion or seek out the contact; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">hire, employ, or engage any person then employed by Company or who has left the employment of Company
within the preceding six months in a business venture as partners or owners or other joint capacity, or attempt to hire, employ, or engage any person then employed by Company or who has left the employment of Company within the preceding six months
in a business venture as partners or owners or other joint capacity; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">solicit, induce, encourage, or participate in an attempt to induce
any Customer or Potential Customer (as defined below), to terminate, diminish, or materially alter in a manner harmful to Company its relationship with Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">solicit or assist in the solicitation of any Customer or Potential Customer to induce or attempt to induce such Customer or Potential Customer
to purchase or contract for any Conflicting Services; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">solicit, induce, encourage or attempt to solicit, induce, or encourage, any
franchisee, joint venture, supplier, vendor or contractor who conducted business with Company at any time during the <FONT STYLE="white-space:nowrap">two-year</FONT> period before the termination of my employment with Company, to terminate or
adversely modify any business relationship with Company or not to proceed with, or enter into, any business relationship with Company, nor will I otherwise interfere with any business relationship between Company and any such franchisee, joint
venture, supplier, vendor or contractor; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">perform, provide or attempt to perform or provide any Conflicting Services for a Customer or
Potential Customer (except as prohibited by law). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this Agreement: (a)&nbsp;a &#147;<B><I>Customer or Potential Customer</I></B>&#148; is
any person or entity who or which used or inquired of Company&#146;s services at any time during the <FONT STYLE="white-space:nowrap">two-year</FONT> period preceding the termination of my employment with Company; and
(b)&nbsp;&#147;<B><I>Conflicting Service</I></B><B>s</B>&#148; means any product, service, or process or the research and development thereof, of any person or organization other than Company that competes with a product, service, or process,
including the research and development thereof, of Company with which I worked directly or indirectly during my employment by Company or about which I acquired Confidential Information during my employment by Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-Compete</FONT> Provision</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent applicable to me or modified for me as described in <B><U>Exhibit D</U></B> based on the jurisdiction in which I work, and
subject to any future modification by Section&nbsp;10.3, for the <FONT STYLE="white-space:nowrap">one-year</FONT> period after the date my employment ends for any reason, including voluntary termination by me or involuntary termination by Company
(except as prohibited by law), I will not, directly or indirectly, as an officer, director, employee, consultant, owner, partner, or in any other capacity solicit, perform, or provide, or attempt to perform or provide Conflicting Services (defined
above) anywhere in the Restricted Territory (defined below), nor will I assist another person to solicit, perform or provide or attempt to perform or provide Conflicting Services anywhere in the Restricted Territory. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The parties agree that, for purposes of this Agreement, &#147;<B><I>Restricted Territory</I></B>&#148; means (a)&nbsp;all counties in the
state or district in which I primarily perform services for Company; (b)&nbsp;all other states or districts of the United States of America in which Company provided goods or services, had customers, or otherwise conducted business at any time
during the <FONT STYLE="white-space:nowrap">two-year</FONT> period before the date of the termination of my relationship with Company; and (c)&nbsp;any other countries in which Company provided goods or services, had customers, or otherwise
conducted business at any time during the <FONT STYLE="white-space:nowrap">two-year</FONT> period before the date of the termination of my relationship with Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Employee Confidential
Information and Inventions Assignment Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page 5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 6 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Reasonableness of Restrictions</B>. I have read this entire Agreement and understand it. I acknowledge
that (a)&nbsp;I have the right to consult with counsel before signing this Agreement, (b)&nbsp;I will derive significant value from Company&#146;s agreement to provide me with Company Confidential Information to enable me to optimize the performance
of my duties to Company, and (c)&nbsp;my fulfillment of the obligations contained in this Agreement, including my obligation neither to disclose nor to use Company Confidential Information other than for Company&#146;s exclusive benefit and my
obligations not to compete and not to solicit are necessary to protect Company Confidential Information and, consequently, to preserve the value and goodwill of Company. I agree that (i)&nbsp;this Agreement does not prevent me from earning a living
or pursuing my career, and (ii)&nbsp;the restrictions contained in this Agreement are reasonable, proper, and necessitated by Company&#146;s legitimate business interests. I represent and agree that I am entering into this Agreement freely, with
knowledge of its contents and the intent to be bound by its terms. If a court finds this Agreement, or any of its restrictions, are ambiguous, unenforceable, or invalid, Company and I agree that the court will read the Agreement as a whole and
interpret such restriction(s) to be enforceable and valid to the maximum extent allowed by law. If the court declines to enforce this Agreement in the manner provided in this Section&nbsp;7 and/or Section&nbsp;13.2, Company and I agree that this
Agreement will be automatically modified to provide Company with the maximum protection of its business interests allowed by law, and I agree to be bound by this Agreement as modified. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Conflicting Agreement or Obligation</B>. I represent that my performance of all the terms of this Agreement and as an employee of Company does not and
will not breach any agreement to keep in confidence information acquired by me in confidence or in trust before my employment by Company. I have not entered into, and I agree I will not enter into, any written or oral agreement in conflict with this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Return of Company Property</B>. When I cease to be employed by Company or upon Company&#146;s earlier request, I will deliver to Company
any and all materials, together with all copies thereof, containing or disclosing any Company Inventions, or Confidential Information. I will not copy, delete, or alter any information contained upon my Company computer or Company equipment before I
return it to Company. In addition, if I have used any personal computer, server, or <FONT STYLE="white-space:nowrap">e-mail</FONT> system to receive, store, review, prepare or transmit any Company information, including Confidential Information, I
will provide Company with (a)&nbsp;a computer-useable copy of all such information and then permanently delete such information from those systems, and (b)&nbsp;access to my system as reasonably requested to verify that the necessary copying and/or
deletion is completed. Any property situated on Company&#146;s premises and owned by Company, including disks and other storage media, filing cabinets or other work areas, is subject to inspection by Company&#146;s personnel at any time during my
employment, with or without notice. Before leaving my employment with Company, I will (i)&nbsp;provide Company any and all information needed to access any Company property or information returned or required to be returned pursuant to this
paragraph, including any login, password, and account information, (ii)&nbsp;cooperate with Company in attending an exit interview, and (iii)&nbsp;complete and sign Company&#146;s termination statement if required to do so by Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Legal and Equitable Remedies. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It may be
impossible to assess the damages caused by my violation of this Agreement or any of its terms. Accordingly, in addition to any remedies available under applicable law and/or as set forth in any equity agreements between me and Company (including
option grant notices), any threatened or actual violation of this Agreement or any of its terms will constitute immediate and irreparable injury to Company, and Company will have the right to enforce this Agreement and any of its provisions by
injunction, specific performance or other equitable relief, without bond and without prejudice to any other rights and remedies that Company may have for a breach or threatened breach of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as prohibited by law or any agreement between Company and me regarding payment of fees charged by an arbitral body, if Company is
successful in whole or in part in any legal or equitable action under this Agreement (including a court partially or fully granting any application, motion, or petition by Company for injunctive relief, including a temporary restraining order,
preliminary injunction, or permanent injunction), whether against or commenced by me, Company will be entitled to recover from me all costs, fees, or expenses it incurred at any time during the course
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Employee Confidential
Information and Inventions Assignment Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page 6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 7 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the dispute, including reasonable attorney&#146;s fees. A final resolution of such dispute or a final judgment is not a prerequisite to Company&#146;s right to demand payment hereunder and
such amounts must be paid by me to Company within 30 days after I receive written notice of such demand. If Company demands only a portion of such costs, fees, or expenses incurred, such demand will be without prejudice to further demands for
(a)&nbsp;the remainder of any outstanding costs, fees, or expenses incurred, or (b)&nbsp;costs, fees, or expenses incurred after the prior demand. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If Company enforces this Agreement through a court order, the restrictions of Section&nbsp;5 and Section&nbsp;6 will remain in effect for a
period of twelve months from the effective date of the order enforcing the Agreement, provided, however, notwithstanding anything to the contrary herein, the restrictions (to the extent applicable to me) will not exceed the maximum duration presumed
reasonable under applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notices</B>. Any notices required or permitted under this Agreement may be sent by certified or registered mail,
courier, express mail, or email delivery. Notices will be given to Company at its headquarters location at the time notice is given, labeled &#147;Attention Chief Executive Officer,&#148; and to me at my address as listed on Company payroll, or at
such other address as Company or I may designate by written notice to the other. Notice will be effective upon receipt or refusal of delivery. If delivered by certified or registered mail, notice will be considered to have been given five business
days after it was mailed, as evidenced by the postmark. If delivered by courier or express mail service, notice will be considered to have been given on the delivery date reflected by the courier or express mail service receipt. If delivered by
email, notice will be considered to have been given upon either receipt of: (i)&nbsp;an acknowledgment or receipt by the recipient of the email, or (ii)&nbsp;electronic confirmation that said email has been opened by the recipient. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Publication of This Agreement to Subsequent Employer or Business Associates of Employee</B>. If I am offered employment, or the opportunity to enter into
any business venture as owner, partner, consultant or other capacity, while the restrictions in Section&nbsp;5 and Section&nbsp;6 are in effect, I will inform my potential employer, partner, <FONT STYLE="white-space:nowrap">co-owner</FONT> and/or
others involved in managing the business I have an opportunity to be associated with, of my obligations under this Agreement. I will inform Company of all employment and business ventures which I enter into while the restrictions described in
Section&nbsp;5 and Section&nbsp;6 are in effect and I authorize Company to provide copies of this Agreement to my employer, partner, <FONT STYLE="white-space:nowrap">co-owner</FONT> and/or others involved in managing the business I have an
opportunity to be associated with and to make such persons aware of my obligations under this Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General Provisions. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Governing Law; Consent to Personal Jurisdiction; Notice of Change to Work Location or Residence</B>. This Agreement will be governed by and
construed according to the laws of the state or district in which I primarily work for Company without regard to any conflict of laws principles that would require the application of the laws of a different jurisdiction. I expressly consent to the
personal jurisdiction and venue of the state and federal courts located in the state or district in which I primarily work for Company and the state or district in which Company&#146;s headquarters is located for any lawsuit filed there against me
by Company arising from or related to this Agreement (although I understand Company will not file a lawsuit in the state or district in which Company&#146;s headquarters is located if prohibited by applicable law). I will not change the state or
district where I am primarily working for the Company or reside, without providing prior written notice to the Company of such change (other than in the case of any such change requested or required of me by the Company). During the <FONT
STYLE="white-space:nowrap">one-year</FONT> period after the date my employment ends for any reason, I will provide written notice to the Company of any changes to the state or district in which I work or reside. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Severability</B>. In case any one or more of the provisions, subsections, or sentences contained in this Agreement will, for any reason, be
held to be invalid, illegal, or unenforceable in any respect, such invalidity, illegality, or unenforceability will not affect the other provisions of this Agreement, and this Agreement will be construed as if such invalid, illegal or unenforceable
provision had never been contained in this Agreement. If moreover, any one or more of the provisions contained in this Agreement will for any reason be held to be excessively broad as to duration, geographical scope, activity or subject, it will be
construed by limiting and reducing it, so as to be enforceable to the extent compatible with the applicable law as it will then appear. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Employee Confidential
Information and Inventions Assignment Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page 7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 8 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Successors and Assigns</B>. This Agreement is for my benefit and the benefit of Company,
its successors, assigns, parent corporations, subsidiaries, affiliates, and purchasers, and will be binding upon my heirs, executors, administrators and other legal representatives. Notwithstanding anything to the contrary herein, Company may assign
this Agreement and its rights and obligations under this Agreement to any successor to all or substantially all of Company&#146;s relevant assets, whether by merger, consolidation, reorganization, reincorporation, sale of assets or stock, or
otherwise. For avoidance of doubt, Company&#146;s successors and assigns are authorized to enforce Company&#146;s rights under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Survival</B>. This Agreement will survive the termination of my employment, regardless of the reason, and the assignment of this Agreement
by Company to any successor in interest or other assignee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Employment <FONT STYLE="white-space:nowrap">At-Will</FONT></B>. I
understand and agree that nothing in this Agreement will change my <FONT STYLE="white-space:nowrap">at-will</FONT> employment status or confer any right with respect to continuation of employment by Company, nor will it interfere in any way with my
right or Company&#146;s right to terminate my employment at any time, with or without cause or advance notice, except as prohibited by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Waiver</B>. No waiver by Company of any breach of this Agreement will be a waiver of any preceding or succeeding breach. No waiver by
Company of any right under this Agreement will be construed as a waiver of any other right. Company will not be required to give notice to enforce strict adherence to all terms of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Export</B>. I will not export, reexport, or transfer, directly or indirectly, any U.S. technical data acquired from Company or any products
utilizing such data, in violation of the United States export laws or regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Counterparts</B>. This Agreement may be executed in
two or more counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature
complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law) or other transmission method and any counterpart so delivered will be deemed to have been duly and validly delivered and be valid and
effective for all purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Advice of Counsel. I ACKNOWLEDGE THAT, IN EXECUTING THIS AGREEMENT, I HAVE HAD THE RIGHT TO SEEK THE
ADVICE OF INDEPENDENT LEGAL COUNSEL, AND I HAVE READ AND UNDERSTOOD ALL OF THE TERMS AND PROVISIONS OF THIS AGREEMENT. THIS AGREEMENT WILL NOT BE CONSTRUED AGAINST ANY PARTY BY REASON OF THE DRAFTING OR PREPARATION OF THIS AGREEMENT</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Entire Agreement</B>. The obligations in Sections&nbsp;1 and 2 (except Section&nbsp;2.2 and Section&nbsp;2.7, with respect to a consulting
relationship) will apply to any time during which I was previously engaged, or am in the future engaged, by Company as a consultant, employee or other service provider if no other agreement governs nondisclosure and assignment of inventions during
such period. This Agreement, together with the Exhibits herein and any executed written offer letter between me and Company, is the final, complete and exclusive agreement between me and Company with respect to the subject matter of this Agreement
and supersedes and merges all prior discussions between us, whether written or oral; <B><I>provided</I></B><I>, </I><B><I>however</I></B>, if, before execution of this Agreement, Company and I were parties to any agreement regarding the subject
matter hereof, that agreement will be superseded by this Agreement prospectively only, except that any restrictive covenant provisions of such agreement will not be superseded and will remain in effect and enforceable without limiting or affecting
the provisions of this Agreement. No modification of or amendment to this Agreement will be effective unless in writing and signed by the party to be charged. Any subsequent change or changes in my duties, salary or compensation will not affect the
validity or scope of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Interpretation</B>.<B> </B>For purposes of this Agreement, whenever the context requires the
singular number includes the plural, and vice versa; the masculine gender includes the feminine and neuter genders; the feminine gender includes the masculine and neuter genders; and the neuter gender includes the masculine and feminine genders; and
any references to sections (unless otherwise specified otherwise) refer to sections of this Agreement. The parties to this Agreement agree </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Employee Confidential
Information and Inventions Assignment Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page 8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 9 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that any rule of construction to the effect that ambiguities are to be resolved against the drafting party will not be applied in the construction or interpretation of this Agreement. As used in
this Agreement, the words &#147;include&#148; and &#147;including,&#148; and variations thereof, will not be deemed to be terms of limitation, but rather will be deemed to be followed by the words &#147;without limitation.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Protected Activity Not Prohibited</B>. I understand that nothing in this Agreement limits or prohibits me from (a)&nbsp;filing a charge or
complaint with, or otherwise communicating or cooperating with or participating in any investigation or proceeding that may be conducted by law enforcement or any federal, state or local government agency, entity, or commission, including the
Securities and Exchange Commission, the Equal Employment Opportunity Commission, the Occupational Safety and Health Administration, and the National Labor Relations Board, including disclosing documents or other information as permitted by law,
without giving notice to, or receiving authorization from, Company; (b)&nbsp;discussing the terms and conditions of my employment with others to the extent expressly permitted by Section&nbsp;7 of the National Labor Relations Act; or
(c)&nbsp;disclosing or communicating information to the extent that such disclosure is protected under the applicable provisions of law or regulation, including but not limited to &#147;whistleblower&#148; statutes or other similar provisions that
protect such disclosure, provided that (i)&nbsp;in each case such communications and disclosures are consistent with applicable law and (ii)&nbsp;the information subject to such disclosure was not obtained by me through a communication that was
subject to the attorney client privilege or otherwise constitutes attorney work product, unless such disclosure of that information would otherwise be permitted by an attorney pursuant to 17 C.F.R. 205.3(d)(2), applicable state attorney conduct
rules, or otherwise. I also understand that nothing in this Agreement prohibits me from discussing or disclosing information (either orally or in writing) that is expressly prohibited from being the subject of employee nondisclosure obligations
under applicable law, such as information about possible or actual unlawful acts in the workplace, including harassment or any other conduct or violation of any U.S. federal, state or local law, regulation, or public policy, or from speaking with an
attorney regarding the same. Any agreement in conflict with the foregoing is hereby deemed amended to be consistent with the foregoing Section&nbsp;13.12. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signatures to follow on next page] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Employee Confidential
Information and Inventions Assignment Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page 9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 1 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Agreement will be effective as of the date signed by the employee below. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>EMPLOYER: Vera Therapeutics, Inc.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>EMPLOYEE: David Johnson</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Marshall Fordyce</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Johnson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">(Signature)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(Signature)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">Marshall Fordyce</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">David Johnson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">(Printed Name)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(Printed Name)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">Chief Executive Officer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">June&nbsp;26, 2024</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">(Title)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(Date Signed)</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="72%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>PRIOR INVENTIONS</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1.</B>&#8195;<B>Prior Inventions Disclosure</B>. Except as listed in Section&nbsp;2 below, the following is a complete list
of all Prior Inventions: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No Prior Inventions.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See below:</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">N/A</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Additional sheets attached.</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2.</B>&#8195;Due to a prior confidentiality agreement, I cannot complete the disclosure under Section&nbsp;1 above with
respect to the Prior Inventions generally listed below, the intellectual property rights and duty of confidentiality with respect to which I owe to the following party(ies): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Excluded Invention</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Party(ies)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Relationship</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>1.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>2.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="99%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Additional sheets attached.</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Employee Confidential
Information and Inventions Assignment Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Signature Page </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 1 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>JURISDICTION-SPECIFIC IP ASSIGNMENT NOTIFICATIONS (AS APPLICABLE) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For California Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that, in accordance with Cal. Lab. Code &#167; 2870, I am not required to assign to Employer any Invention that I develop entirely on my own time without using Employer&#146;s equipment, supplies, facilities, or trade secret information,
except for those inventions that either: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) Relate at the time of conception or use to Employer&#146;s business, or actual or demonstrably anticipated
research or development; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(2) Result from any work I perform for Employer. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Delaware Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that, in accordance with Del. Code Ann., Title 19, &#167; 805, I am not required to assign to Employer any Invention that I develop entirely on my own time without using Employer&#146;s equipment, supplies, facilities or trade secret
information, except for those inventions that either: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) Relate to Employer&#146;s business, or actual or demonstrably anticipated research or
development; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(2)<B> </B>Result from any work performed by me for Employer. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Illinois Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that, in accordance with Chapter 765 Section&nbsp;1060/2 of the Illinois Compiled Statutes, I am not required to assign to Employer any Invention that I develop entirely on my own time without using Employer&#146;s equipment, supplies,
facilities or trade secret information except for those inventions that either: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) Relate to Employer&#146;s business, or actual or demonstrably
anticipated research or development of Employer; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(2) Result from any work performed by me for Employer. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Kansas Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that, in accordance with K.S.A. &#167; <FONT STYLE="white-space:nowrap">44-130(a),</FONT> I am not required to assign to Employer any Invention that I develop entirely on my own time and for which no equipment, supplies, facilities, or
trade secret information of Employer was used, unless the invention either: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) Relates to Employer&#146;s business, or actual or demonstrably
anticipated research or development; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(2) Results from any work I perform for Employer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 2 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Minnesota Employees Only </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that, in accordance with Section&nbsp;181.78 of the Minnesota Statutes, I am not required to assign to Employer any Invention that I develop
entirely on my own time for which no equipment, supplies, facility or trade secret information of Employer was used, and: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) Does not relate
(a)&nbsp;directly to the business of Employer or (b)&nbsp;to Employer&#146;s actual or demonstrably anticipated research or development, or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(2) Does not
result from any work performed by me for Employer. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Nevada Employees Only </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that, in accordance with NRS &#167; 600.500, unless there is an express written agreement to the contrary, Employer is the sole owner of any
&#147;patentable invention or trade secret&#148; developed by me during the course and scope of my employment that relates directly to work performed during the course and scope of employment. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For New Jersey Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that, in accordance with <FONT STYLE="white-space:nowrap">Section&nbsp;34:1B-265</FONT> of the New Jersey Statutes, I am not required to assign to Employer any Invention that I develop entirely on my own time without using Employer
equipment, supplies, facilities, or trade secret information, except for those inventions that either: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) Relate to Employer&#146;s business, or actual
or demonstrably anticipated research or development; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(2) Result from any work performed by me on behalf of Employer. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For New York Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that, in accordance with N.Y. Lab. Law &#167; <FONT STYLE="white-space:nowrap">203-f,</FONT> I am not required to assign to Employer any Invention that I develop entirely on my own time without using Employer&#146;s equipment, supplies,
facilities, or trade secret information, except for those inventions that either: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) Relate at the time of conception or use to Employer&#146;s
business, or actual or demonstrably anticipated research or development; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(2) Result from any work I perform for Employer. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For North Carolina Employees Only </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that, in accordance with North Carolina General Statute &#167;&#167; 66.57.1 and 66.57.2, I am not required to assign to Employer any Invention
that I develop entirely on my own time without using Employer&#146;s equipment, supplies, facilities or trade secret information except for those inventions that either: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) Relate at the time of conception or reduction to practice of the invention to Employer&#146;s business, or actual or demonstrably anticipated research or
development of Employer; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(2) Result from any work performed by me for Employer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 3 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that I have the burden of establishing that any invention is excluded from assignment to
Employer by the preceding paragraph. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that this limited exclusion does not apply to any patent or invention covered by a contract between
Employer and the United States or any of its agencies requiring full title to such patent or invention to be in the United States. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Utah Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that, in accordance with Utah Code &#167;&#167; <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">34-39-1</FONT></FONT> to <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">34-39-3,</FONT></FONT> I am not
required to assign to Employer any Invention that is both (i)&nbsp;created by me on my own time, and (ii)&nbsp;not an &#147;employment invention.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An &#147;employment invention&#148; means an invention or any part that is: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Conceived, developed, or reduced to practice or created by me: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">within the scope of my employment; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on Employer&#146;s time; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">with the aid, assistance, or use of any of Employer&#146;s property, equipment, facilities, supplies, resources,
or intellectual property. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The result of any work, services, or duties performed by me for Employer. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Related to Employer&#146;s industry or trade. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Related to Employer&#146;s current or demonstrably anticipated business, research, or development.
</P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Washington Employees Only </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that, in accordance with Section&nbsp;49.44.140 of the Revised Code of Washington, I am not required to assign to Employer any Invention that I
develop entirely on my own time and for which no equipment, supplies, facilities, or trade secret information of Employer was used, unless: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) The
invention relates (a)&nbsp;directly to the business of Employer, or (b)&nbsp;to Employer&#146;s actual or demonstrably anticipated research or development; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(2) The invention results from any work performed by me for Employer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 1 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT B </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>JURISDICTION-SPECIFIC MODIFICATIONS TO SECTION&nbsp;4 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(AS APPLICABLE) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For
District of Columbia Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;4 of this Agreement will be replaced in its entirety with the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During my employment by Company, I will not, without Company&#146;s written consent, directly or indirectly engage in any outside employment or business
activity that Company reasonably believes will: (i)&nbsp;result in my disclosure or use of Company&#146;s Confidential Information; (ii)&nbsp;conflict with Company&#146;s, industry&#146;s or my profession&#146;s rules regarding conflicts of
interest; (iii)&nbsp;constitute a conflict of commitment (if I am employed by a higher education institution); or (iv)&nbsp;impair Company&#146;s ability to comply with any District or federal laws or regulations, contract, or grant agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 1 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT C </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>JURISDICTION-SPECIFIC <FONT STYLE="white-space:nowrap">NON-SOLICITATION</FONT> MODIFICATIONS TO SECTION&nbsp;5 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(AS APPLICABLE) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For
Alabama Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that I agree to this Section&nbsp;5 in order to protect Company&#146;s protectable business interests
pursuant to Ala. Code &#167;&#167; <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">8-1-190</FONT></FONT> to <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">8-1-197.</FONT></FONT> I acknowledge that during my
employment I will have access to and knowledge of Confidential Information and such Confidential Information contains trade secrets pursuant to Ala. Code &#167; <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">8-27-2.</FONT></FONT>
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Arizona Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that Section&nbsp;5 of this Agreement will be replaced in its entirety with the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&#8195;I agree that, subject to
future modification by Section&nbsp;10.3, during the period of my employment and for the one (1)&nbsp;year period after the date my employment ends for any reason, including voluntary termination by me or involuntary termination by Company, I will
not, as an officer, director, employee, consultant, owner, partner, or in any other capacity, either directly or through others, except on behalf of Company: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">solicit, induce, encourage, or participate in soliciting, inducing or encouraging any person known to me to be
an employee, consultant, or independent contractor of Company to terminate his or her relationship with Company, even if I did not initiate the discussion or seek out the contact; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">solicit, induce, encourage, or participate in soliciting, inducing, or encouraging any person known to me to be
an employee, consultant, or independent contractor of Company to terminate his or her relationship with Company to render services to me or any other person or entity that researches, develops, markets, sells, performs or provides or is preparing to
develop, market, sell, perform or provide Conflicting Services (as defined below); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">hire, employ, or engage in a business venture with as partners or owners or other joint capacity, or attempt to
hire, employ, or engage in a business venture as partners or owners or other joint capacity, with any person then employed by Company or who has left the employment of Company within the preceding three (3)&nbsp;months to research, develop, market,
sell, perform or provide Conflicting Services; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">solicit, induce or attempt to induce any Customer (as defined below), to terminate, diminish, or materially
alter in a manner harmful to Company its relationship with Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">solicit or assist in the solicitation of any Customer to induce or attempt to induce such Customer to purchase
or contract for any Conflicting Services; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">perform, provide or attempt to perform or provide any Conflicting Services for a Customer.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The parties agree that for purposes of this Agreement, a &#147;<B><I>Customer</I></B>&#148; is any person or entity who or which, at
any time during the one (1)&nbsp;year period prior to my contact with such person or entity as described in <FONT STYLE="white-space:nowrap">Sections&nbsp;5.4-5.6</FONT> above if such contact occurs during my employment or, if such contact occurs
following the termination of my employment, during the one (1)&nbsp;year period prior to the date my employment with Company ends contracted for, was billed for, or received from Company any product, service or process with which I worked directly
or indirectly during my employment by Company or about which I acquired Confidential Information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The parties agree that for purposes of this Agreement,
&#147;<B><I>Conflicting Services</I></B>&#148; means any product, service or process or the research and development thereof, of any person or organization other than the Company that directly competes with a product, service or process, including
the research and development thereof, of Company with which I worked directly or indirectly during my employment by Company or about which I acquired Confidential Information during my employment by Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 2 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the duration of this Section&nbsp;5 is found by a court of competent jurisdiction to be unenforceable,
then the duration shall be during the period of my employment and for the nine (9)&nbsp;month period after the date my employment ends for any reason. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Arkansas Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that I agree to this Section&nbsp;5 in order to protect Company&#146;s legitimate business interests pursuant to <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Section&nbsp;4-75-101</FONT></FONT> of the Arkansas Code.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For California Employees Only </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that the restrictions contained in Section&nbsp;5.1 of this Agreement shall apply only with respect to persons then employed by Company, or any
person or entity engaged by Company as a consultant or independent contractor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that
<FONT STYLE="white-space:nowrap">Sections&nbsp;5.2-5.8</FONT> of this Agreement will not apply to me. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Colorado Employees Only
</U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that Section&nbsp;5 of this Agreement will not apply to me. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Florida Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that I agree to this Section&nbsp;5 in order to protect Company&#146;s legitimate business interests pursuant to Fla. Stat. Section&nbsp;542.335. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Georgia Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that, for purposes of Section&nbsp;5 of the Agreement, references to &#147;<B><I>Potential Customer</I></B>&#148; will not apply to me. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
further acknowledge and agree that for the <FONT STYLE="white-space:nowrap">one-year</FONT> period after the date my employment ends for any reason, <FONT STYLE="white-space:nowrap">Sections&nbsp;5.1-5.4</FONT> shall only apply to solicitation
within the Restricted Territory, as defined in Section&nbsp;6.2. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Hawaii Employees Only </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that Section&nbsp;5 of this Agreement will not apply to me if I am employed by a &#147;technology business&#148; as defined by Haw. Rev. Stat. <FONT
STYLE="white-space:nowrap">480-4.</FONT> </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Indiana Employees Only </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that, for purposes of Section&nbsp;5 of the Agreement, references to &#147;<B><I>Potential Customer</I></B>&#148; will not apply to me. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 3 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Illinois Employees Only </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge and understand that Section&nbsp;5 of the Agreement shall apply to me only if my actual or expected annualized rate of earnings exceeds the
applicable earnings threshold under the Illinois Freedom to Work Act (820 ILSC 90/10). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that, for purposes of the Agreement, references to
&#147;<B><I>Customer or</I></B> <B><I>Potential Customer</I></B>&#148; shall mean any person or entity who or which, at any time during the <FONT STYLE="white-space:nowrap">one-year</FONT> period prior to my contact with such person or entity as
described in Sections&nbsp;5.5 or 5.6 if such contact occurs during my employment or, if such contact occurs following the termination of my employment, during the <FONT STYLE="white-space:nowrap">one-year</FONT> period prior to the date my
employment with Company ends: (i)&nbsp;contracted for, was billed for, or received from Company any product, service or process with which I worked directly or indirectly during my employment by Company or about which I acquired Confidential
Information; or (ii)&nbsp;was in contact with me or in contact with any other employee, owner, or agent of Company, of which contact I was or should have been aware, concerning the sale or purchase of, or contract for, any product, service or
process with which I worked directly or indirectly during my employment with Company or about which I acquired Confidential Information; or (iii)&nbsp;was solicited by Company in an effort in which I was involved or of which I was aware. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Louisiana Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that I agree to this Section&nbsp;5 in order to protect Company&#146;s legitimate business interests pursuant to La. R.S. 23:921. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that for purposes of Section&nbsp;5 of the Agreement, references to &#147;<B><I>Potential Customer</I></B>&#148; will not apply to me. In addition, Section&nbsp;5 of the Agreement will only apply to areas within the Ascension, East Baton
Rouge, East Feliciana, Iberville Jefferson, Livingston, Orleans, Plaquemines, Pointe Coupee, St. Bernard, St. Tammany, St. Charles, St. Helena, St. John the Baptist, St. James, West Baton Rouge, and West Feliciana parishes of Louisiana, which I
acknowledge and agree are the parishes where I conduct business for Company in Louisiana. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Minnesota Employees Only </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that, for purposes of Section&nbsp;5 of the Agreement, references to &#147;<B><I>Potential Customer</I></B>&#148; will not apply to me. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Missouri Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that, for purposes of Section&nbsp;5 of the Agreement, references to &#147;<B><I>Potential Customer</I></B>&#148; will not apply to me. I further acknowledge that Section&nbsp;5 of the Agreement will not apply to me if I am an employee
who provides only secretarial or clerical services. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Nevada Employees Only </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that nothing contained in Section&nbsp;5 of this Agreement is intended to prohibit me from providing otherwise lawful services pursuant to
N.R.S. &#167;613.195. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 4 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For New Hampshire Employees Only </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that, for purposes of Section&nbsp;5 of the Agreement, references to &#147;<B><I>Potential Customer</I></B>&#148; will not apply to me. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For North Dakota Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that Section&nbsp;5 of the Agreement will not apply to me. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For South Dakota Employees Only </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that, for purposes of Section&nbsp;5 of the Agreement, references to &#147;<B><I>Potential Customer</I></B>&#148; will not apply to me. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Oklahoma Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that, for purposes of Section&nbsp;5 of the Agreement, references to &#147;<B><I>Potential Customer</I></B>&#148; will not apply to me. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Oregon Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that, for purposes of Section&nbsp;5 of the Agreement, references to &#147;<B><I>Potential Customer</I></B>&#148; will not apply to me. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Tennessee Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that, for purposes of Section&nbsp;5 of the Agreement, references to &#147;<B><I>Potential Customer</I></B>&#148; will not apply to me. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Virginia Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that Section&nbsp;5 of this Agreement will be replaced in its entirety with the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&#8195;I agree that, subject to
future modification by Section&nbsp;10.3, during the period of my employment and for the <FONT STYLE="white-space:nowrap">one-year</FONT> period after the date my employment ends for any reason, including voluntary termination by me or involuntary
termination by Company, I will not, as an officer, director, employee, consultant, owner, partner, or in any other capacity, either directly or through others, except on behalf of Company: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">solicit, induce, encourage, or participate in soliciting, inducing or encouraging any person known to me to be
an employee, consultant, or independent contractor of Company to terminate his or her relationship with Company, even if I did not initiate the discussion or seek out the contact; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">solicit, induce, encourage, or participate in soliciting, inducing, or encouraging any person known to me to be
an employee, consultant, or independent contractor of Company to terminate his or her relationship with Company to render services to me or any other person or entity that researches, develops, markets, sells, performs or provides or is preparing to
develop, market, sell, perform or provide Conflicting Services (as defined below); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">hire, employ, or engage in a business venture with as partners or owners or other joint capacity, or attempt to
hire, employ, or engage in a business venture as partners or owners or other joint capacity, with any person then employed by Company or who has left the employment of Company within the preceding three months to research, develop, market, sell,
perform or provide Conflicting Services; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 5 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">solicit, induce or attempt to induce any Customer or Potential Customer (as defined below), to terminate,
diminish, or materially alter in a manner harmful to Company its relationship with Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">solicit or assist in the solicitation of any Customer or Potential Customer to induce or attempt to induce such
Customer or Potential Customer to purchase or contract for any Conflicting Services; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">perform, provide or attempt to perform or provide any Conflicting Services for a Customer or Potential
Customer. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The parties agree that for purposes of this Agreement, a &#147;<B><I>Customer or Potential Customer</I></B>&#148; is any
person or entity who or which, at any time during the <FONT STYLE="white-space:nowrap">one-year</FONT> period before my contact with such person or entity as described in Sections&nbsp;5.4-5.6 above if such contact occurs during my employment or, if
such contact occurs after the termination of my employment, during the <FONT STYLE="white-space:nowrap">one-year</FONT> period before the date my employment with Company ends: (i)&nbsp;contracted for, was billed for, or received from Company any
product, service or process with which I worked directly or indirectly during my employment by Company or about which I acquired Confidential Information; or (ii)&nbsp;was in contact with me or in contact with any other employee, owner, or agent of
Company, of which contact I was or should have been aware, concerning the sale or purchase of, or contract for, any product, service or process with which I worked directly or indirectly during my employment with Company or about which I acquired
Confidential Information; or (iii)&nbsp;was solicited by Company in an effort in which I was involved or of which I was aware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The parties agree that for
purposes of this Agreement, <I>&#147;</I><B><I>Conflicting Services</I></B>&#148; means any product, service, or process or the research and development thereof, of any person or organization other than Company that directly competes with a product,
service, or process, including the research and development thereof, of Company with which I worked directly or indirectly during my employment by Company or about which I acquired Confidential Information during my employment by Company. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Washington Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that Section&nbsp;5 of this Agreement will be replaced in its entirety with the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&#8195;I agree that, subject to
future modification by Section&nbsp;10.3, during the period of my employment and for the <FONT STYLE="white-space:nowrap">one-year</FONT> period after the date my employment ends for any reason, including voluntary termination by me or involuntary
termination by Company, I will not, as an officer, director, employee, consultant, owner, partner, or in any other capacity, either directly or through others, except on behalf of Company: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1 solicit, induce, encourage, or participate in soliciting, inducing or encouraging any person known to me to be an employee of Company to
terminate his, her or their relationship with Company, even if I did not initiate the discussion or seek out the contact; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 solicit,
induce, encourage, or participate in soliciting, inducing or encouraging any person known to me to be an employee to render services to me or to any other person or entity that researches, develops, markets, sells, performs or provides or is
preparing to develop, market, sell, perform or provide Conflicting Services (as defined below); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3 solicit, induce, encourage, or
participate in soliciting, inducing, or encouraging any person known to me to be a consultant or independent contractor of Company to terminate his, her or their relationship with Company, (even if I did not initiate the discussion or seek out the
contact) or render services to me or any other person or entity that researches, develops, markets, sells, performs or provides or is preparing to develop, market, sell, perform or provide Conflicting Services; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 6 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4 hire, employ, or engage in a business venture to research, develop, market, sell, perform
or provide Conflicting Services as partners or owners or other joint capacity any person then employed by Company or who has left the employment of Company within the preceding three months, or attempt to hire, employ, or engage in a business
venture to research, develop, market, sell, perform or provide Conflicting Services as partners or owners or other joint capacity any person then employed by Company or who has left the employment of Company within the preceding three months; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.5 solicit, induce or attempt to induce any Customer (as defined below), to terminate, diminish, or materially alter in a manner harmful to
Company its relationship with Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.6 solicit or assist in the solicitation of any Customer to induce or attempt to induce such
Customer to purchase or contract for any Conflicting Services; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.7 perform, provide, or attempt to perform or provide any Conflicting
Services for a Customer; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.8 solicit, induce, or attempt to induce any Potential Customer (as defined below), to terminate, diminish,
or materially alter in a manner harmful to Company its relationship with Company; solicit or assist in the solicitation of any Potential Customer to induce or attempt to induce such Potential Customer to purchase or contract for any Conflicting
Services; or perform, provide or attempt to perform or provide any Conflicting Services for a Potential Customer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The parties agree that for purposes of
this Agreement, a &#147;<B><I>Customer&#148; or &#147;Potential Customer</I></B>&#148; is any person or entity who or which, at any time during the <FONT STYLE="white-space:nowrap">one-year</FONT> period prior to my contact with such person or
entity as described in Sections&nbsp;5.5-5.8 above if such contact occurs during my employment or, if such contact occurs following the termination of my employment, during the <FONT STYLE="white-space:nowrap">one-year</FONT> period prior to the
date my employment with Company ends: (i)&nbsp;contracted for, was billed for, or received from Company any product, service or process with which I worked directly or indirectly during my employment by Company or about which I acquired Confidential
Information; or (ii)&nbsp;was in contact with me or in contact with any other employee, owner, or agent of Company, of which contact I was or should have been aware, concerning the sale or purchase of, or contract for, any product, service or
process with which I worked directly or indirectly during my employment with Company or about which I acquired Confidential Information; or (iii)&nbsp;was solicited by Company in an effort in which I was involved or of which I was aware. The parties
agree that, for purposes of this Agreement, &#147;<B><I>Conflicting Service</I></B><B>s</B>&#148; means any product, service, or process or the research and development thereof, of any person or organization other than Company that directly competes
with a product, service, or process, including the research and development thereof, of Company with which I worked directly or indirectly during my employment by Company or about which I acquired Confidential Information during my employment by
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I understand that Sections&nbsp;5.2-5.4 and 5.6-5.8 are applicable to me only if my total annualized compensation meets or exceeds the
Compensation Threshold specified in Section&nbsp;6, calculated as of the earlier of my employment separation date or the date the Company seeks to enforce the restrictions in this Section&nbsp;5. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Wisconsin Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that, for purposes of Section&nbsp;5 of the Agreement, references to &#147;<B><I>Potential Customer</I></B>&#148; will not apply to me. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 10.1 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g799103g0702111704948.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT D </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>JURISDICTION-SPECIFIC <FONT STYLE="white-space:nowrap">NON-COMPETITION</FONT> MODIFICATIONS TO SECTION&nbsp;6 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(AS APPLICABLE) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For
Alabama Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that I agree to this Section&nbsp;6 in order to protect Company&#146;s protectable business interests
pursuant to Ala. Code &#167;&#167; <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">8-1-190</FONT></FONT> to <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">8-1-197.</FONT></FONT> I acknowledge that during my
employment I will have access to and knowledge of Confidential Information and such Confidential Information contains trade secrets pursuant to Ala. Code &#167; <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">8-27-2.</FONT></FONT>
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Arizona Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that Section&nbsp;6 of this Agreement will be replaced in its entirety with the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I agree that, subject to future modification by
Section&nbsp;10.3, for the one (1)&nbsp;year period after the date my employment ends for any reason, including voluntary termination by me or involuntary termination by Company (except as prohibited by law), I will not, directly or indirectly, as
an officer, director, employee, consultant, owner, partner, or in any other capacity solicit, perform, or provide, or attempt to perform or provide Conflicting Services (as defined for Arizona employees in <B><U>Exhibit C</U></B>) anywhere in the
Restricted Territory (as defined below), nor will I assist another person to solicit, perform or provide or attempt to perform or provide Conflicting Services anywhere in the Restricted Territory. <B></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The parties agree that for purposes of this Agreement, &#147;<B><I>Restricted Territory</I></B>&#148; means (i)&nbsp;anywhere in the State of Arizona;
(ii)&nbsp;within a fifty (50)&nbsp;mile radius of the principal location of my employment with Company during the last one (1)&nbsp;year of my employment with Company, if such fifty (50)&nbsp;mile radius encompasses a state other than Arizona; and
(iii)&nbsp;within a fifty (50)&nbsp;mile radius of the primary business location of a Customer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the duration of this Section&nbsp;6 is found by a
court of competent jurisdiction to be unenforceable, then the duration shall be during the period of my employment and for the nine (9)&nbsp;month period after the date my employment ends for any reason. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Arkansas Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that I agree to this Section&nbsp;6 in order to protect Company&#146;s legitimate business interests pursuant to <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Section&nbsp;4-75-101</FONT></FONT> of the Arkansas Code.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For California Employees Only </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that Section&nbsp;6 of this Agreement will not apply to me. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Colorado Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that Section&nbsp;6 of this Agreement will not apply to me. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For District of Columbia Employees Only </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge and understand that Section&nbsp;6 shall apply to me only if my annualized compensation (including, but not limited to salary, commissions, and
bonuses) meets or exceeds the greater of (i)&nbsp;$154,200; or (ii)&nbsp;the compensation threshold as adjusted pursuant to D.C. Code <FONT STYLE="white-space:nowrap">&#167;32-581.01</FONT> (the &#147;Washington D.C. Compensation Threshold&#148;).
If my annualized compensation meets or exceeds the Washington D.C. Compensation Threshold, I acknowledge that I received notice of the restrictions in Section&nbsp;6, including the following notice below, pursuant to D.C. Code <FONT
STYLE="white-space:nowrap">&#167;32-581.01:</FONT> </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE PURSUANT TO D.C. CODE &#167;
<FONT STYLE="white-space:nowrap">32-581.01</FONT> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">The District&#146;s Ban on
<FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreements Amendment Act of 2020 limits the use of <FONT STYLE="white-space:nowrap">non-compete</FONT> agreements. It allows employers to request <FONT STYLE="white-space:nowrap">non-compete</FONT>
agreements from highly compensated employees, as that term is defined in the Ban on <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreements Amendment Act of 2020, under certain conditions. [&#8195;&#8195;&#8195;] has determined that you are a
highly compensated employee. For more information about the Ban on <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreements Amendment Act of 2020, contact the District of Columbia Department of Employment Services (DOES). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Florida Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that I agree to this Section&nbsp;6 in order to protect Company&#146;s legitimate business interests pursuant to Fla. Stat. Section&nbsp;542.335. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Georgia Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that Section&nbsp;6 of this Agreement will not apply to me if I do not (i)&nbsp;customarily and regularly solicit for Company&#146;s customers or prospective customers; (ii)&nbsp;customarily and regularly engage in making sales or
obtaining orders or contracts for products or services; (iii)&nbsp;perform the following duties: have a primary duty of managing the enterprise in which I am employed or of a customarily recognized department or subdivision, customarily and
regularly direct the work of two or more other employees, and have the authority to hire or fire other employees or have particular weight given to suggestions and recommendations as to the hiring, firing, advancement, promotion, or any other change
of status of other employees; or (iv)&nbsp;perform the duties of a key employee or professional, pursuant to O.C.G.A. &#167; <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">13-8-53(a).</FONT></FONT> </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Hawaii Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge<B> </B>that Section&nbsp;6 of this Agreement will not apply to me if I am employed by a &#147;technology business&#148; as defined by Haw. Rev. Stat. <FONT STYLE="white-space:nowrap">480-4.</FONT> I acknowledge that I agree to this
Section&nbsp;6 in order to protect Company&#146;s legitimate business interests pursuant to <FONT STYLE="white-space:nowrap">Section&nbsp;480-4</FONT> of the Hawaii Revised Statutes. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Idaho Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that this Section&nbsp;6 protects Company&#146;s legitimate business interests, including its interests in Company&#146;s trade secrets and Confidential Information, its substantial and near permanent relationships with customers, and
its customer goodwill. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that Section&nbsp;6 of this Agreement will not apply to me if I am not a &#147;key&#148; employee or &#147;key&#148;
independent contractor, as defined under Idaho Code &#167; <FONT STYLE="white-space:nowrap">44-2702(1).</FONT> </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Illinois
Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that this Section&nbsp;6 protects Company&#146;s legitimate business interests, including its interests in
Company&#146;s trade secrets and Confidential Information, its substantial and near permanent relationships with customers, and its customer goodwill. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge and understand that Section&nbsp;6 of the Agreement shall apply to me only if my actual or
expected annualized rate of earnings exceeds the applicable earnings threshold under the Illinois Freedom to Work Act (820 ILSC 90/10). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Indiana Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that this Section&nbsp;6 protects Company&#146;s legitimate business interests, including its interests in Company&#146;s trade secrets and Confidential Information, its substantial and near permanent relationships with customers, and
its customer goodwill. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Louisiana Employees Only </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that I agree to this Section&nbsp;6 in order to protect Company&#146;s legitimate business interests pursuant to La. R.S. 23:921. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that, for purposes of Section&nbsp;6 of the Agreement, references to &#147;<B><I>Restricted Territory</I></B>&#148; will only apply to areas
within the Ascension, East Baton Rouge, East Feliciana, Iberville Jefferson, Livingston, Orleans, Plaquemines, Pointe Coupee, St. Bernard, St. Tammany, St. Charles, St. Helena, St. John the Baptist, St. James, West Baton Rouge, and West Feliciana
parishes of Louisiana, which I acknowledge and agree are the parishes where I conduct business for Company in the State of Louisiana. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Maine Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that, pursuant to 26 M.R.S.A. &#167; <FONT STYLE="white-space:nowrap">599-A,</FONT> Section&nbsp;6 of this Agreement will not apply to me if (i)&nbsp;I earn wages at or below 400% of the federal poverty level, or (ii)&nbsp;if Company did
not provide notice to me of a <FONT STYLE="white-space:nowrap">non-compete</FONT> requirement and did not provide a copy of this Agreement at least three business days before Company required the Agreement to be signed. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Maryland Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that Section&nbsp;6 of this Agreement will not apply to me if I earn less than 150% of the state&#146;s minimum wage, pursuant to Md. Code Ann., Lab. &amp; Empl. &#167; <FONT STYLE="white-space:nowrap">3-716(a).</FONT> </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Massachusetts Employees Only </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that, in support of my agreement to the <FONT STYLE="white-space:nowrap">non-competition</FONT> provision in Section&nbsp;6, Company has
provided or will provide to me (as applicable) with Mutually Agreed Upon Consideration, or in the alternative, Garden Leave Payments, each as defined and detailed below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#147;<B><I>Mutually Agreed Upon Consideration</I></B>&#148; is, at Company&#146;s election and sole discretion, either (A)&nbsp;the option grant
described in my offer letter or employment agreement, as applicable; (B)&nbsp;the award of restricted stock, as described in my offer letter or employment agreement, as applicable; or (C)&nbsp;as described below. Notwithstanding the foregoing, in
the event that I have no such option grant or award of restricted stock as of the date on which my employment terminates, and if Company does not elect to waive the provisions of this Section&nbsp;6, Company will either, at its election,
(A)&nbsp;provide me with Mutually Agreed Upon Consideration by paying me a lump sum payment of $10,000, less applicable deductions and withholdings, on Company&#146;s next regular payroll date which occurs at least fifteen days after my employment
terminates; or (B)&nbsp;pay me continuing salary payments for one year following termination of my employment at a rate equal to no less than 50% of the highest annualized base salary paid to me by Company within the two years prior to the
termination of my relationship with Company (&#147;<B><I>Garden Leave Payments</I></B>&#148;). Company may elect to enforce the provisions of this Section&nbsp;6 or waive them at its sole discretion. If Company elects to waive the provisions of this
Section&nbsp;6, such waiver may be accomplished by Company providing me with written notice of its election to waive: (A)&nbsp;on or before the last day of my employment with Company pursuant to an involuntary termination by Company for Cause, or
(B)&nbsp;within two weeks after Company&#146;s receipt of written notice from me of my resignation from employment. Notwithstanding anything to the contrary above, Company may enforce the covenants in this Section&nbsp;6 without providing the
Mutually Agreed Upon </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Consideration or Garden Leave Payments, as applicable, if it determines in good faith that I breached this Section&nbsp;6 or unlawfully misappropriated Company&#146;s physical or electronic
property. For avoidance of doubt, Company&#146;s failure to timely waive the provisions of this Section&nbsp;6 shall be construed as its election to enforce the provisions of this Section&nbsp;6. For further avoidance of doubt, if Company elects to
waive, I am classified as nonexempt under the Fair Labor Standards Act, 29 U.S.C. <FONT STYLE="white-space:nowrap">201-219,</FONT> or Company is otherwise prohibited by law or a court from enforcing, the provisions of this Section&nbsp;6, I will not
be subject to the restrictions in this Section&nbsp;6 nor will I be entitled to any Mutually Agreed Upon Consideration, to the extent that it has not already been provided to me, or Garden Leave Payments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I agree that for purposes of this Agreement, &#147;<B><I>Cause</I></B>&#148; shall mean a termination of my employment by the Company due to my misconduct or
failure to meet the Company&#146;s performance expectations </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I agree that for purposes of this Agreement, &#147;<B><I>Restricted Territory</I></B>&#148;
means the geographic areas in which I provided services for Company or had a material presence or influence, during any time within the last two years prior to the termination of my relationship with Company. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Michigan Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that this Section&nbsp;6 protects Company&#146;s legitimate business interests, including its interests in Company&#146;s trade secrets and Confidential Information, its unique business relationships, and its customer goodwill. I
acknowledge that Section&nbsp;6 is necessary to protect these legitimate business interests. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Minnesota Employees Only
</U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that Section&nbsp;6 of this Agreement will not apply to me. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Missouri Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that I agree to this Section&nbsp;6 in order to protect Company&#146;s legitimate business interests pursuant to Section&nbsp;416.031 of the Missouri Revised Statutes. I acknowledge that this Section&nbsp;6 is necessary to protect those
legitimate business interests. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that Section&nbsp;6 of this Agreement will not apply to me if I am an employee who provides only clerical or
secretarial services. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Montana Employees Only </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that Section&nbsp;6 of the Agreement is reasonably necessary to protect Company&#146;s legitimate business interests in good will, customer
relationships, and trade information pursuant to Mont. Code Ann. &#167;&#167; <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">28-2-703</FONT></FONT> to
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">28-2-705.</FONT></FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that Section&nbsp;6 of the Agreement does not
operate as an absolute or full restraint on my right to work. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that Section&nbsp;6 of the Agreement will not apply to me if I am terminated
by Company. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Nevada Employees Only </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that Section&nbsp;6 of this Agreement will not apply to me if I am paid on an hourly basis. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For New Hampshire Employees Only </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that, pursuant to N.H. RSA &#167; 275:70, that this Section of this Agreement will not apply to me after the termination of my employment,
unless (i)&nbsp;Company provided me a copy of this Agreement before I accepted my offer of employment, if this was a condition of employment before my employment with Company, and (ii)&nbsp;I earn an hourly wage of more than 200% of the federal
minimum wage. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For North Dakota Employees Only </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that Section&nbsp;6 of this Agreement will not apply to me. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Ohio Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that this Section&nbsp;6 protects Company&#146;s legitimate business interests, including its interests in Company&#146;s trade secrets and Confidential Information and its customer goodwill. I acknowledge that Section&nbsp;6 is
necessary to protect these legitimate business interests. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Oklahoma Employees Only </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that Section&nbsp;6 of this Agreement will not apply to me. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Oregon Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that either (a)&nbsp;Company informed me in a written employment offer received by me at least two weeks before my first day of work that a noncompetition agreement is required as a condition of employment or (b)&nbsp;this noncompetition
agreement is entered into upon my subsequent bona fide advancement by Company. I understand Company reserves all of the options under ORS 653.295 for enforcement of this noncompetition agreement for up to one year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that this Section&nbsp;6 of the Agreement will not apply to me if I am classified as a nonexempt employee under the federal Fair Labor Standards
Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that this Section&nbsp;6 of the Agreement will only apply to me if the total amount of my annual gross salary and commissions,
calculated on an annual basis, at the time of my termination, exceeds $113,241.00 in 2024 dollars, adjusted annually for inflation. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Rhode Island Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that this Section&nbsp;6 of this Agreement will not apply to me if I am (i)&nbsp;classified as a nonexempt employee under the federal Fair Labor Standards Act; (ii)&nbsp;an undergraduate or graduate student participating in an internship
or otherwise entering into a short-term employment relationship with Company while enrolled at an educational institution; (iii)&nbsp;under the age of 18; or (iv)&nbsp;an employee who earns less than 250% of the federal poverty level for individuals
as established by the United States Department of Health and Human Services federal poverty guidelines. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For South Dakota Employees
Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that I agree to this Section&nbsp;6 in order to protect Company&#146;s legitimate business interests pursuant to SDCL <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">53-9-8</FONT></FONT> through SDCL <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">53-9-11.</FONT></FONT> </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Utah Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that I agree to this Section&nbsp;6 in order to protect Company&#146;s legitimate business interests pursuant to Utah Code &#167;&#167; <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">34-51-101</FONT></FONT> to <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">34-51-301.</FONT></FONT> </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Virginia Employees Only </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that Section&nbsp;6 of this Agreement will be replaced in its entirety with the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I agree that, subject to future modification by Section&nbsp;10.3, for the <FONT STYLE="white-space:nowrap">one-year</FONT> period after the date my
employment ends for any reason, including voluntary termination by me or involuntary termination by Company (except as prohibited by law), I will not, directly or indirectly, as an officer, director, employee, consultant, owner, partner, or in any
other capacity </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
solicit, perform, or provide, or attempt to perform or provide Conflicting Services (as defined for Virginia employees in <B><U>Exhibit C</U></B>) anywhere in the Restricted Territory (as defined
below), nor will I assist another person to solicit, perform or provide or attempt to perform or provide Conflicting Services anywhere in the Restricted Territory<B>.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The parties agree that for purposes of this Agreement, &#147;<B><I>Restricted Territory</I></B>&#148; means the
<FONT STYLE="white-space:nowrap">100-mile</FONT> radius of any of the following locations: (i)&nbsp;any Company business location at which I have worked on a regular or occasional basis during the preceding year; (ii)&nbsp;my home if I work from
home on a regular or occasional basis; (iii)&nbsp;any potential business location of Company under active consideration by Company to which I have traveled in connection with the consideration of that location; (iv)&nbsp;the primary business
location of a Customer or Potential Customer; or (v)&nbsp;any business location of a Customer or Potential Customer where representatives of the Customer or Potential Customer with whom I have been in contact in the preceding year are based. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that this Section&nbsp;6 of this Agreement will not apply to me if my average weekly earnings, as determined pursuant to Code of Virginia <FONT
STYLE="white-space:nowrap">&#167;40.1-28.7:7,</FONT> are less than the average weekly wage of the Commonwealth as determined by Va. Code Ann. &#167; <FONT STYLE="white-space:nowrap">65.2-500(B).</FONT> </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Washington Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that Section&nbsp;6 of this Agreement will only apply to me after the termination of my employment for any reason if my total annualized compensation (such as salary, commissions and bonuses), calculated as of the earlier of my
employment separation date or the date Company seeks to enforce the restrictions in Section&nbsp;6, meets or exceeds the greater of (i)&nbsp;$120,559.99; or (ii)&nbsp;the compensation threshold established by the Washington State Department of Labor
and Industries (collectively, the &#147;<B><I>Compensation Threshold</I></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I acknowledge that in the event that my employment is terminated as
the result of a &#147;layoff&#148; (under applicable Washington law), Company may elect to enforce any portion (or entirety) of the <FONT STYLE="white-space:nowrap">one-year</FONT> restricted period specified in this Section&nbsp;6, or waive them at
its sole discretion. To the extent required under Washington law, if Company elects to enforce the provisions of this Section&nbsp;6 after my employment is terminated as a result of such a layoff, Company will provide me continuing salary payments
for that portion (or entirety) of the <FONT STYLE="white-space:nowrap">one-year</FONT> restricted period specified in this Section&nbsp;6 which Company elects to enforce, following termination of my employment at a rate equal to no less than my base
salary at the time of the termination of my employment, less any compensation earned through my subsequent employment (&#147;<B><I>Garden Leave Payments</I></B>&#148;). Notwithstanding anything to the contrary above, Company may enforce the
covenants in Section&nbsp;6 without providing the Garden Leave Payments, if applicable, if it determines in good faith that I breached Section&nbsp;6 or unlawfully misappropriated Company&#146;s physical or electronic property. I agree that upon a
request from Company, I will provide Company with proof of my new wage rate or salary through subsequent employment for the purposes of calculating Garden Leave Payments, which may be adjusted from payment to payment based on the information I
provide to Company. For further avoidance of doubt, if my annualized compensation does not meet or exceed the Compensation Threshold (as defined in this <B><U>Exhibit D</U></B>), I will not be subject to the restrictions in Section&nbsp;6. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>For Wisconsin Employees Only </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
acknowledge that this Section&nbsp;6 protects Company&#146;s legitimate business interests, including its interests in Company&#146;s trade secrets and Confidential Information, relationships with customers or recent past customers, and its customer
goodwill. I acknowledge that Section&nbsp;6 is reasonably necessary to protect these legitimate business interests as defined by Wis. Stat. &#167; 103.465. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I further acknowledge that Section&nbsp;6 of the Agreement will only apply to Conflicting Services related to my particular division or product line at
Company. Pursuant to Wis. Stat. &#167; 103.465, Section&nbsp;6 of the Agreement does not prohibit me from engaging in activities that are not in direct competition with Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 10.1 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g799103g0702111704948.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>E<SMALL>XHIBIT</SMALL> B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF RELEASE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
exchange for the severance benefits to be provided to me by Vera Therapeutics, Inc. (the &#147;<B>Company</B>&#148;) pursuant to my employment offer letter agreement between me and the Company, dated [DATE] (the &#147;<B>Employment
Agreement</B>&#148;), I hereby provide the following release. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I hereby generally and completely release the Company and its parents,
subsidiaries, successors, predecessors, and affiliates, and each of their respective current and former directors, officers, employees, stockholders, shareholders, agents, attorneys, insurers, and assigns, from any and all claims, liabilities and
obligations, both known and unknown, that arise out of or are in any way related to events, acts, conduct, or omissions occurring at any time prior to and including the date I sign this release. This general release includes, but is not limited to:
(a)&nbsp;all claims arising out of or in any way related to my employment or the termination of that employment; (b)&nbsp;all claims related to my compensation or benefits, including salary, bonuses, commissions, vacation pay, expense
reimbursements, severance pay, fringe benefits, stock, stock options, or any other ownership interests; (c)&nbsp;all claims for breach of contract, wrongful termination, and breach of the implied covenant of good faith and fair dealing; (d)&nbsp;all
tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (e)&nbsp;all federal, state, provincial and local statutory claims, including claims for discrimination, harassment,
retaliation, attorneys&#146; fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal Americans with Disabilities Act of 1990 (as amended), the federal Employee Retirement Income Security Act of 1974 (as
amended), the federal Age Discrimination in Employment Act (as amended) (&#147;<B>ADEA</B>&#148;), the California Labor Code, and the California Fair Employment and Housing Act (as amended).<B> </B>Notwithstanding the foregoing, I understand that
the following claims are not included in my release: (a)&nbsp;any rights or claims for indemnification I may have pursuant to any written indemnification agreement; the charter, bylaws, or operating agreements of the Company; or under applicable
law; (b)&nbsp;any rights I have to file or pursue a claim for workers&#146; compensation or unemployment insurance; or (c)&nbsp;any rights which cannot be waived as a matter of law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>I acknowledge that I have been advised, pursuant to California Government Code Section</B><B></B><B>&nbsp;12964.5(b)(4), that I have a
right to consult an attorney regarding this release and that I was given a reasonable time period of not less than five business days in which to do so.</B> I further acknowledge and agree that, in the event I sign this release prior to the end of
the reasonable time period, my decision to accept such shortening of time is knowing and voluntary and is not induced by the Company through fraud, misrepresentation, or a threat to withdraw or alter the offer prior to the expiration of the
reasonable time period, or by providing different terms to employees who sign such an agreement prior to the expiration of the time period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I acknowledge that I am knowingly and voluntarily waiving and releasing any rights I may have under the ADEA, and that the consideration for
the waiver and release in the preceding paragraph hereof is in addition to anything of value to which I was already entitled. I further acknowledge that I have been advised by this writing, as required by the ADEA, that: (a)&nbsp;my waiver and
release do not apply to any rights or claims that may arise after the date I sign this release; (b)&nbsp;I should consult with an attorney prior to signing this release (although I may choose voluntarily not do so); (c)&nbsp;I have 21 days to
consider this release (although I may choose voluntarily to sign this release earlier); (d)&nbsp;I have seven days following the date I sign this release to revoke it by providing written notice to the Board of Directors; and (e)&nbsp;this release
will not be effective until the date upon which the revocation period has expired, which will be the eighth day after I sign this release. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I acknowledge that I have read and understand Section&nbsp;1542 of the California Civil Code
which reads as follows: <B>&#147;A general release does not extend to claims which the creditor or releasing party does not know or </B><B>suspect to exist in his or her favor at the time of executing the release and that, if known by him or her,
would have materially affected his or her settlement with the debtor or released party.&#148;</B> I hereby expressly waive and relinquish all rights and benefits under that section and any law of any jurisdiction of similar effect with respect to my
release of any claims hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, I understand that nothing in this release limits my ability to file a charge or complaint
with the Equal Employment Opportunity Commission, the Department of Labor, the National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission or any other federal, state or local
governmental agency or commission (&#147;<B>Government Agencies</B>&#148;). I further understand this release does not limit my ability to communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may
be conducted by any Government Agency, including providing documents or other information, without notice to the Company. While this Agreement does not limit my right to receive an award for information provided to the Securities and Exchange
Commission, I understand and agree that, to maximum extent permitted by law, I am otherwise waiving any and all rights I may have to individual relief based on any claims that I have released and any rights I have waived by signing this release. I
further understand that nothing in this release prevents me from discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that I have reason to believe is unlawful, or
waives any rights I may have under Section&nbsp;7 of the National Labor Relations Act (subject to the release of claims set forth herein). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I hereby represent that I have been paid all compensation owed and for all hours worked; I have received all the leave and leave benefits and
protections for which I am eligible pursuant to the Family and Medical Leave Act, the California Family Rights Act, or otherwise; and I have not suffered any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">on-the-job</FONT></FONT>
injury for which I have not already filed a workers&#146; compensation claim. I further acknowledge that, other than the severance benefits that will be provided to me pursuant to the Employment Agreement upon the effectiveness of this release,
among other required conditions, I have not earned and will not receive from the Company any additional compensation, severance, or benefits, with the exception of any vested right I may have under the express terms of a written ERISA-qualified
benefit plan (e.g., 401(k) account). By way of example, I acknowledge that I have not earned and am not owed any bonus, vacation, incentive compensation, severance, commissions or equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I further acknowledge my continuing obligations under my Employee Confidential Information and Inventions Assignment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Both I and the Company hereby agree not to disparage the other party (and, as it relates to you, nor any of Company&#146;s officers,
directors, employees, shareholders, and agents) in any manner likely to be harmful to its or their business, business reputations or personal reputations; provided that either party may respond accurately and fully to any question, inquiry or
request for information when required by the legal process or in connection with a government investigation. In addition, nothing in this release is intended to prohibit or restrain me in any manner from making disclosures that are protected under
the whistleblower provisions of federal law or regulation or under other applicable law or regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I acknowledge that to become
effective, I must sign and return this release to the Company so that it is received not later than 21 days following the date it is provided to me. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>D<SMALL>AVID</SMALL>
J<SMALL>OHNSON</SMALL></B></P></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>vera-20240626.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 7/2/2024 11:56:57 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:vera="http://veratx.com/20240626"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://veratx.com/20240626"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vera-20240626_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vera-20240626_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>vera-20240626_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 7/2/2024 11:56:57 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>vera-20240626_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 7/2/2024 11:56:57 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="vera-20240626.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g799103g0702111704948.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g799103g0702111704948.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  M 'H# 2(  A$! Q$!_\0
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MQ%:0_995DBDC\R5D(.1A2%'ZU[N,XYZUSUH1B_=ES&D6WNK'D_[0'_(E:?\
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&-8WMJ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm140719848520512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 26, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001831828<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 26,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Vera Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-2744449<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">8000 Marina Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Brisbane<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(650)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">770-0077<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Class&#160;A common stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VERA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MKBZ?(Y0G5F7%O?M"6:N2XG M."Q5=P'\OE3*OI^XQP'5TYS1?U!+ P04
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MJ'7N0;#W\!J-'<V/'[?\ 5!+ P04    " "[@.)8)!Z;HJT   #X 0  &@
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I0P5,
M75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LIDR^SO
M *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\./VR
M./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/
M3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ NX#B6&60>9(9 0  SP,
M !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +
M77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5
M!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP
M39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM
M2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>
M,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]
M#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4
M" "[@.)8!T%-8H$   "Q    $               @ $     9&]C4')O<',O
M87!P+GAM;%!+ 0(4 Q0    ( +N XEA_&QWL[P   "L"   1
M  "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( +N XEB97)PC
M$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL
M4$L! A0#%     @ NX#B6-9^1+^)!   V1$  !@              ("!#@@
M 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( +N XEB?H!OP
ML0(  .(,   -              "  <T,  !X;"]S='EL97,N>&UL4$L! A0#
M%     @ NX#B6)>*NQS     $P(   L              ( !J0\  %]R96QS
M+RYR96QS4$L! A0#%     @ NX#B6!PX9>H_ 0  / (   \
M ( !DA   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( +N XE@D'INBK0
M /@!   :              "  ?X1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<U!+ 0(4 Q0    ( +N XEAED'F2&0$  ,\#   3              "
M >,2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  "T4
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d799103d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d799103d8k.htm">d799103d8k.htm</File>
    <File>vera-20240626.xsd</File>
    <File>vera-20240626_lab.xml</File>
    <File>vera-20240626_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d799103d8k.htm": {
   "nsprefix": "vera",
   "nsuri": "http://veratx.com/20240626",
   "dts": {
    "inline": {
     "local": [
      "d799103d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "vera-20240626.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "vera-20240626_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "vera-20240626_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "report": {
    "R1": {
     "role": "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-06-26_to_2024-06-26",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d799103d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-06-26_to_2024-06-26",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d799103d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://veratx.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-24-174318-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-174318-xbrl.zip
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MF+W>GM5O(OG<+^JZF/)7HR*OMZKTOY/7.^[SR$S3;/'Z(ITF572<7$5GQ=3
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MGC0:3\WDIN,PI@YP@3')<+36UYJ>G&*>L3LV^33#:47GS:<Z$7-#EYI(-?M
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M8O"0\[ XQMFX0I.8&I%UW!]:\Y1](S9*;&-EQ@:PT:\:I*9WDU\Z9*WPL03
M"-G@4A,PA"" \C;06)QU'S:[ A)J26^P(BNE3G).K-QHV-E@0)O%+$JE#L5\
M.S 9YJA .MP-,Z)+O]2'MZH_76SPH"]2KIVQ"5-2;W*<4_5*KT?>S-GRJC34
M/O;?4[JHQRW&@)>]];6+5C/ZZ')D[B_<&%)ODV#:GNK7>)-68UG21I]S23G9
M;1PP3'+E1LS)?3J=(FFSC(--</ ('RA1I3G=_HMURKU!<B)=VNX"DEQ3DT"J
M%&GSUE4S_CY$"HB,,$(S09);(A'UQ!:=NU/DV\XSY^5M@"UY5X3(8PW'FM"
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MM(I-2\&0F?D_J.&E0MFM.TI%3>C*\1_A[4?'Q>.5[AL0"D<<\VY-VFJ[;;T
MO;0>]K@7?4@_)OA7;!4BU%W^9=O+[K]Q65RIC"%?JR@]N'3)\VVQX42YY"7N
MX4(@K7:*3%*EJR;F-]<AH -B-^'"5U]\V)O83BTV O=.W=Z8UJ'ENPRD.(^U
MGRQOY/I:TV??$+>MS4]SX>4J6R8SI6%96-8]6"-#!#O53/9(-;WL8(1.HN8(
MXZJX0B('9>E HP++_;0+"C?MHV8UQHK/.&57L*S)8)TPCW)K,7FB0MOE!:@I
M7XF7L2K/W#Y7/)V:S@E2T!%W@X)*T 7O+0N\VJ&&7#LT\Q;6M9AU([;W;%$
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MUF/&;>[=PA8.M7"KV$^)I"VM_M$N-DV>6.._SM$*4$$A>7?[1:V9$<U1*O'
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MXRG:'>].S@X.S^AK:0)_LP7&RH>]T_/#U_K'RCXU!T#,$6S2V5OYXR"P>,
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MOJ>DEY5NZ+MB$SUC @V=!GML<!D$VC?RH8K.*'#X)CKV-P6W_+=%X]!4I_V
M682XX)KUN..K%/_'A&;(KX\)!DU@[BV."G_"00A6' / $9;=(4S+@LI:]N0>
M@H$1SQBF7@6 VS K_DEO9S<.B?IMJ;RA$%<L$=4%$JGR?O &PZ]E3N,,.WE>
M43$5JL1(D+;85I^ON-[%L@[Y $T+$^W(0Y\N.#2"04H_?]14 7;$E4_W%DQ/
M>\2(2%=XEFXT6>M&Q\ ML;@CVSDIB3/O3X5KBCJI*!:XPQX"&_*:F,!FKHPO
MEV[@&)D,H*V;B:2%4O"I6CELMDM8ZE0 PE;48JJ%F4M8S>$[NTX@]_3UM>#Q
M3;:VVF?MB8,$W)V7FF3;X&-X\F2COVF7DT ")DDVI K1*9/DH&Z;7J89L9\8
MB]#@M)-F-I5_1C)1C !?PWZ9\$(<:X^5+*V8Q"9EQ5N7-L7E0H))FC0FF'1Y
M7+Q.4B(18H#%$!;MH,ZT:I%\XO3F@HB<!)DL>$VN7J!-EW"[I-<('0T]Z1)C
MHV/F&T#R#Y([A'CP*BD3O!Y9/G=;W>-*2)S19)??^II2W4A"'=/2FZMJGGI0
M!3]M2<L;2A:<OD *@20FZWDI@4X(PK,"5AU7_NHH4 .[-/I8(#*98,T5MYG6
M>M(N5]1C*H7%Z",ML^UV-!W;7/,:X0K%59X59LA)/YC43C(;YV:Z<"3B<ZX(
MI0FQ3%S$11:*>4VY4OA"TFM$]Y7ZKYZ\^C8DC,M&B8_&T"I;=J5O8A"W6A6P
M<01@>4^;IRH0QA]]1<E1/DLER.V5-],P^^>F5@QC6!)_<#!Q(KF+E4:<".T$
M"]9Z$*E;#-5%-8 +VOKY^ARKGU>,C"ER+.0)RPE/$"4-4:A,+WJ'8"K*Y@%1
M-J\$Z+Z^%M",R/)<JC;8@;&I/(%1$'N9!_#W$"2^)$Q5!-?!!\TS_+(J1O45
M<_/#W_-RP 7-.+UK0+SE.+I@<2>#25YDQ7AQ _L!9V=K4EQ9PV&8L-5/0X5/
M2A'/$;/*Y)""=' +XD'!7XS<B>T:0OHE2L)&)?M4-RXK==%&0Y=*<[_DFB.3
M:R1R^XO;V=LMKX/#A^%#=8EX!OK&LK(VN[V=S3?K:RZQR9M+E["$T%)3(C',
M$ [BK)BQ@,,BT3(H,&2VD@E5:IF)\<'%?G/Z'78%7CC/1:U",<45]A +I;AZ
M2PCQMRCO6("QPAM9MG#V+2&X\"?0ME*+<)^!H4H"_U]S*2QH>25BY8^DYO $
M<RGZ,=?X-C-8WME6:3@36%J=*JE6Q61:Y#E"$%PB$%?]Y!\<;UR=OB#SAN!
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MWDVGM&-$GSRA&EV56!7^.2->,/Z+EA'F'M(:P+\P@D3?3,EFC&U-+]I<R(,
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M'ZLQ3"BYM6(A95JU8$V@=ONX)D4U\9?A)];8WUG@$Q4&UZW=A)'K^8'&PPT
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MIQW<:C\KJ4XW75)K17A\7%4GNXYD9L;:SUB6V4!R@FOF4.6D7X87V:S?B"B
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MU!SG4"-649K8=5H2%YM+U^P7.==MUB] K/\-@SK0NL#RA-)1C-@Y#I@%B6M
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MY+N#&SN6S,4D$#]-'R8Y5!Z"3_<;?'KY$'QZ"#ZM"CZ]^I&2M9PZ,>=(@GC
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MQ@A/I_4U2_EJBT<)J%G/J*#%T#-+[-EQKMW.4/1/LOB^3C(= /(;?8[:V=W
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MQ+_S8(!+"K\@H1S9%OD0%=HM.-]GH(-$VN%?[L1@0.H,?SGO"[A)QK]\#J(
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M5DN4$N*\<CX<XJ$3A#C%=$NPF7!#^O((.:V6RE;\@G)"=B2#3&2ZJ"VC"Y%
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M55>*M0QBLK;*K>*2%9YJ%*\5.82Y"GMBDPK1O8W@:!Z'_\ZMASK1T)F<CP7
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M4@+R6:+$!8A<G(^ 5VRZV<$2<3D.'LVQ-L*:=):@%V%:L\C4GM)N*1-)RVO
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M$A?X(78:H,6/0<^2T97*\T]*CEKK\H56B)OM-ZJC%Z=WRM3*XBVR6(0*XM+
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M#*2#!"AF(I7#+J8]BBZ%;V)P)::(6R,.MC8,2<7ARD;LXZ8$VY)1%]Q.5!&
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MSO>/.7W^;T\'"=STY[Q6QN$4O\^=S_Y9-NL&HOY0;G2SX*SA_?+]O(Z K#3
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M-ZW4$!+FHX.&75%F9H4Z'PC8MNK-RB0'L.K8R X#_/L>![PE$&9A=E3%<S%
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M$**Z!%^T;4&ZLQ6R26>)LXC0S)A;/[YQ(L42?>41EGBV_/Z'[9+K8*\N]WC
M/*R\/F/^F4=O\<B_4$L! A0#%     @ NX#B6,B</X5!%P  UX,   X
M         ( !     &0W.3DQ,#-D.&LN:'1M4$L! A0#%     @ NX#B6"<F
M'>)BH@  G(L# !$              ( !;1<  &0W.3DQ,#-D97@Q,#$N:'1M
M4$L! A0#%     @ NX#B6)M,F;TZ P  .@L  !$              ( !_KD
M '9E<F$M,C R-# V,C8N>'-D4$L! A0#%     @ NX#B6'*V7)2K!@  I$D
M !4              ( !9[T  '9E<F$M,C R-# V,C9?;&%B+GAM;%!+ 0(4
M Q0    ( +N XEAE#U-]V00  /,M   5              "  47$  !V97)A
G+3(P,C0P-C(V7W!R92YX;6Q02P4&      4 !0!  0  4<D

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>d799103d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="vera-20240626.xsd" xlink:type="simple"/>
    <context id="duration_2024-06-26_to_2024-06-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001831828</identifier>
        </entity>
        <period>
            <startDate>2024-06-26</startDate>
            <endDate>2024-06-26</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-307">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-06-26_to_2024-06-26"
      id="Hidden_dei_EntityCentralIndexKey">0001831828</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-318">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-319">2024-06-26</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-320">Vera Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-321">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-322">001-40407</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-323">81-2744449</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-324">8000 Marina Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-325">Suite 120</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-326">Brisbane</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-327">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-328">94005</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-329">(650)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-330">770-0077</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-331">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-332">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-333">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-334">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-335">Class&#160;A common stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-336">VERA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-337">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-338">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-339">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
